Bioconversion of reduced c1 compounds

By expressing polypeptides with limited formaldehyde to formate oxidation capacity and using the ribulose monophosphate cycle, the recombinant methylotrophic microorganisms efficiently convert methanol into value-added products, addressing the inefficiencies of existing strains.

WO2026239344A1PCT designated stage Publication Date: 2026-11-19ETH ZURICH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2026/054839
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-15
Filing Date
2026-05-15
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing recombinant methylotrophic E. coli strains inefficiently convert methanol into value-added products due to significant formate production, which is toxic and reduces product yield, and contaminates metabolites.

Method used

Engineering recombinant methylotrophic microorganisms to express a polypeptide with reduced formaldehyde to formate oxidation capacity, utilizing the ribulose monophosphate cycle and specific Mdh/Mdhl class enzymes to channel methanol into central carbon metabolism, minimizing formate production.

Benefits of technology

Enhances the efficiency of methanol conversion into biomass or value-added products by reducing formate accumulation, improving product yield and reducing contamination.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IB2026054839_19112026_PF_FP_ABST
    Figure IB2026054839_19112026_PF_FP_ABST
Patent Text Reader

Abstract

The invention concerns a recombinant non-naturally occurring methanol-dependent or fully methylotrophic microorganism, which heterologously expresses or over-expresses a polypeptide having methanol dehydrogenase (Mdh) activity, wherein the initial maximum velocity of the oxidization of formaldehyde to formate reaction (VmaxCH2O) catalysed by said polypeptide having Mdh activity measured as [nMNADH second-1 µMenzyme -1], is less than 1, or less than 0.1. The invention also concerns a recombinant Mdh polypeptides and a method for producing microbial metabolites and products from C1 compounds, such as methanol.
Need to check novelty before this filing date? Find Prior Art

Description

Bioconversion of reduced Cl compoundsTechnical domain

[0001] The present invention concerns recombinant microorganisms converting methanol into carbon metabolites.Related art

[0002] The release of greenhouse gases (GHG) from anthropogenic sources over the last two centuries has caused a global climate crisis, driving the need for sustainable approaches to mitigate GHG emissions. Achieving a zero-emission chemical industry requires the replacement of fossil feedstocks with CO₂-based alternatives. Among these, the one-carbon compound methanol is an attractive sustainable feedstock because it can be produced renewably from GHG (e-methanol) or biomass (biomethanol) at scale and at competitive costs.

[0003] Biological cell factories have attracted increasing interest for converting methanol into a wide range of value-added products. Natural methylotrophs, which have been studied intensively over many decades, have been used and engineered for methanol-based production. Substantial progress has been made; however, they have not yet been adopted in large-scale industrial processes.

[0004] As an alternative approach, four independently engineered and evolved Escherichia coli strains which are capable of growing on methanol as sole carbon source have been reported as of today. These reports are particularly promising, as E. coli is a well-established and readily scalable species widely used in biological fermentation and production processes.

[0005] Kim S. et al. (Nat. Chem. Biol. (2020), DOI:10.1038 / s41589-020-0473-5) for example describes a genetically altered E. coli strain, which metabolises methanol through the reductive glycine pathway. Additional heterologous expression of a methanol dehydrogenase rendered this strain capable of growing on methanol.ETHZ-37-PCT

[0006] WO2018148703A1 discloses a method for increasing production of a metabolite by a non-naturally occurring methylotroph when grown on a medium comprising methanol. Methanol is metabolised using a heterologous methanol dehydrogenase and the ribulose monophosphate (RuMP) cycle.

[0007] W02024018304A1 and Keller et al (Nat. Comm. (2022), DOI: 10.1038 / s41467-022-32744-9) disclose recombinant fully methylotrophic E. coli strains, capable of converting methanol and other Cl compounds into value added microbial products through the RuMP cycle.

[0008] Chen F. Y-H. et al (Cell (2020), DOI:10.1016 / j.cell.2020.07.010) reported formate formation when methanol is metabolized through the RuMP cycle in a synthetic methanol-dependent strain.

[0009] Meng et al. (Nat. Comm. (2025), DOI: 10.1038 / s41467-024-55502-5) have recently described another synthetic methanol assimilation pathway for E. coli.

[0010] All of the genetically engineered methylotrophic E. coli strains described to date channel formaldehyde generated from enzymatic methanol oxidation into its central carbon metabolism. To allow for an economic and efficient methanol-based bioproduction, methanol should preferably be channelled exclusively into the desired product with minimal generation of unwanted by-products.

[0011] Efficiency however remains a major challenge today, in particular since recombinant methylotrophic E. coli strains have been found to accumulate significant amounts of formate, in some cases over 10 mM, as an unwanted side-product during aerobic growth. Formate may for example be formed via E. coli's native glutathionedependent formaldehyde detoxification pathway. However, in synthetic methylotrophy, this detoxification pathway is commonly inactivated to redirect carbon flux towards biomass. Deactivation of this pathway is usually achieved by deleting the frmA gene coding for the S-(hydroxymethyl)glutathione dehydrogenase or the entire frmRAB operon. Gene deletions have either been introduced by genetic engineering, or have been observed during evolution experiments. Formate production in these strains thus appears to occur independently from this detoxification pathway.ETHZ-37-PCT

[0012] Formate as a side product becomes toxic to bacteria when present above 50 mM and probably also at even lower concentrations. In addition, formic acid formed in the growth supernatant is corrosive and reduces the pH of the growth medium. This unwanted formate side-production thus severely hampers biomass production and reduces product yield.

[0013] Moreover, since formate cannot be assimilated by the recombinant methylotrophic E. coli strains, its carbon is lost, which in turn further lowers product yield. As a further drawback, the accumulated formate contaminates metabolites which are produced using these strains.

[0014] It is therefore highly desirable to reduce the production of formate in the microbial bioconversion of methanol, thereby increasing the efficiency of converting methanol into biomass or into value-added microbial products.Short disclosure of the invention

[0015] It is an aim of the present invention to provide recombinant methylotrophic microorganisms, which overcome the shortcomings and limitations of the state of the art.

[0016] It is another aim of the invention to reduce the amount of formate formed during the bioconversion of methanol into biomass or into value added microbial products.

[0017] It is another aim of this invention to render the bioconversion of Cl compounds to value-added chemicals more efficient.

[0018] It is yet another aim of this invention to provide an alternative recombinant methylotrophic microorganism suitable for industrial bioconversion of methanol.

[0019] According to the invention, one or more of these aims are attained by the object of the attached claims, and especially by the independent claims. Further optional embodiments are provided in the dependent claims.ETHZ-37-PCT

[0020] In particular, one or more of these aims are attained by a recombinant non-naturally occurring methylotrophic microorganism, which heterologously expresses or over-expresses a polypeptide having methanol dehydrogenase (Mdh) activity, wherein the maximum velocity of the oxidization of formaldehyde to formate reaction (VmaxCH₂O) catalysed by said polypeptide measured as [μM NADH second⁻¹ μM enzyme⁻¹], is less than 1, or less than 0.1 or 0.

[0021] The Mdh activity is determined in vitro using the Mdh enzyme assay utilizing the absorption change of the solution at 340 nm to quantify NADH and with this indirectly also formaldehyde for the reaction from methanol to formaldehyde or formate for the reaction from formaldehyde to formate. The VmaxCH₂O of the Mdh enzymes was determined by monitoring NADH production at 340 nm in an Mdh in vitro assay buffered at pH 7.4 with formaldehyde provided at 50 mM to 500 mM. The buffer system may be a phosphate buffer system. Vmax was determined under these near-saturating or under saturated formaldehyde concentrations.

[0022] VmaxCH₂O was determined according to Michaelis-Menten kinetics. Vmax is generally determined using initial rate measurements.

[0023] The assay temperature was selected based on the thermal stability and optimal activity profile of the enzyme tested. For mutant variants, the temperature is determined by the thermal properties of the wild-type parent enzyme. For Mdh polypeptides derived from wild-type parent enzyme originating from mesophilic species, the activity profile is generally tested at 37 °C. For Mdh polypeptides derived from wild-type parent enzyme originating from thermophilic species, the activity profile is generally tested at 50 °C.

[0024] For Mdh2 CT4-1 Cn, which is sensitive to elevated temperatures, assays were conducted at 37 °C. For Mdh Bm MGA3, assays were performed at both 37 °C and 50 °C, the latter representing the temperature optimum for this enzyme's source organism. At 50 °C, the enzyme demonstrates superior activity. For the mutant variant, assays were conducted at 50 °C to exploit its enhanced thermostability.

[0025] In one embodiment the recombinant strain is a methanol-dependent strain.ETHZ-37-PCT

[0026] In an alternative embodiment the recombinant strain is a fully methylotrophic strain.

[0027] The recombinant non-naturally occurring methylotrophic microorganism may express a polypeptide having 3-hexulose-6-phosphate synthase (Hps) activity, and a polypeptide having 6-phospho 3-hexuloisomerase (Phi) activity.

[0028] In one embodiment, the microorganism either does not comprise, or comprises deletions or reductions of expression of, or eliminations or reductions of activity of a polypeptide having triose-phosphate-isomerase activity and of a polypeptide having glutathione-dependent formaldehyde dehydrogenase activity.

[0029] The microorganism may be a synthetic methylotroph comprising one or more of the deletions or point mutations identified by Keller et al., Nat. Comm. (2020), DOI: 10.1038 / S41467-020-19235-5.

[0030] The maximum velocity of the oxidization of methanol to formaldehyde (Vmax CH3OH) measured as [μM NADH second⁻¹ μM enzyme⁻¹] catalysed by said polypeptide having Mdh activity may be at least 25 times higher, or at least 50 times higher, or at least 100 times higher than the maximum velocity of the oxidization of formaldehyde to formate reaction (VmaxCH₂O), measured as [μM NADH second⁻¹ μM enzyme⁻¹] catalysed by said polypeptide having Mdh activity.

[0031] The first metabolic step shared by all natural methylotrophic bacteria for growth on methanol is its oxidation to formaldehyde.

[0032] All synthetically engineered methylotrophic E. coli strains described to date employ NAD-dependent Mdh as the methanol-oxidizing enzyme. The choice of an NAD-dependent enzyme is justified by its ease of expression in E. coli and by the cell's ability to readily utilize NADH in its electron transport chain.

[0033] To channel formaldehyde generated from methanol oxidation into central carbon metabolism, the ribulose monophosphate (RuMP) cycle was introduced into recombinant methylotrophic E. coli strains. This highly efficient pathway requires the heterologous expression of only two additional genes, 3-hexulose 6-phosphateETHZ-37-PCTsynthase (hps) and 6-phospho 3-hexulosiomerase (phi). In this pathway, formaldehyde condenses with ribulose 5-phosphate to form hexulose 6-phosphate, thereby directly integrating the toxic intermediate into biomass and potential products.

[0034] To render bioproduction from methanol as efficient as possible, a maximum amount of the formaldehyde needs to enter the RuMP metabolic cycle and losses, for example in the form of formate, which cannot enter the RuMP cycle, should be avoided.

[0035] By providing for an enzyme having Mdh activity which oxidizes methanol to formaldehyde, but which is not able or only has a limited capacity to oxidize formaldehyde to formate, this loss of Cl compound for the central metabolism of the methylotrophic microbe is avoided. Thus, the Mdh polypeptide used in this invention channels the assimilated Cl compound into the central metabolism while avoiding wasteful production of formate.

[0036] VmaxCH₂O, the maximum velocity of the reaction catalysed by said polypeptide having Mdh activity, measured as [μM NADH second⁻¹ μM enzyme⁻¹] as determined in vitro using the protocols described in the Methods section below, is less than 1, or less than 0.1 or 0.

[0037] When VmaxCHzO is assessed using in vivo experiments, these values may be higher, as formate accumulation may also arise from metabolic sources within the recombinant microorganism other than from the heterologously expressed Mdh enzyme.

[0038] Synthetic methylotrophic Escherichia coli strains utilizing the RuMP cycle described today produce substantial amounts of formate under aerobic growth conditions, which was confirmed by this invention.

[0039] Results of this invention demonstrated that the formate build-up is due to the inherent property of NAD-dependent methanol dehydrogenase Mdh2 from Cupriavidus necator to overoxidize methanol to formate and showed that this feature is widespread among NAD-dependent Mdhs in general and common to all NAD-dependent Mdhs of the overoxidizing class.ETHZ-37-PCT

[0040] Moreover, it was found that Bacillus methanolicus Mdhs, previously grouped as Mdh / Mdhl class enzymes based on sequence analysis, do not overoxidize methanol but catalyze the oxidation of methanol to formaldehyde but not formate. As formaldehyde, but not formate, is assimilated via the ribulose monophosphate (RuMP) pathway, these findings explain the physiological importance of Mdh / Mdhl paralogs in natural methylotrophs and highlight the need to select appropriate Mdh variants for synthetic methylotrophy.

[0041] In one embodiment, the Mdh polypeptide is therefore selected from the phylogenetic Mdh / Mdhl class of Mdh enzymes. These non-overoxidizing enzymes, which are not oxidizing methanol to formate but merely to formaldehyde, are highly similar to each other and form a distinct phylogenetic class with at least 30% difference in amino acid sequence than any other Mdh.

[0042] In one embodiment the polypeptide having a Mdh activity has at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to the Mdh Bm MGA3 polypeptide (SEQ ID NO 1).

[0043] The Mdh / Mdhl class comprises the following members, which have either been described previously or identified in the National Center for Biotechnology Information (NCBI) database:Mdh Bm MGA3 (SEQ ID NO 1), Mdh Bm PB1 (SEQ ID NO 2), Mdhl Bm PB1 (SEQ ID NO 3), Mdh Bm Cl (SEQ ID NO 4), Adhl Bm (SEQ ID NO 5), Adh2 Bm (SEQ ID NO 6).

[0044] Two conserved regions in the Mdh / Mdhl class enzymes which are less than 80% identical to the homologous regions of Mdh2 / Mdh3 class enzymes were identified as being close to the active site, which was identified based on structural comparisons to known alcohol dehydrogenases. The two regions are considered to be relevant for the catalytic activity of the Mdh enzymes. It is assumed that at least one, or both of these regions define the ability, or lack thereof, of the Mdh enzymes to overoxidize methanol to formate.

[0045] These conserved regions are:ETHZ-37-PCTRegion 1, corresponding to residues 184 to 205 of Mdh Bm MGA3 (SEQ ID NO 1): AGLTIATGMDALSHAIEAYVAK (SEQ ID NO 13), andRegion 2, corresponding to residues 248 to 284 of Mdh Bm MGA3 (SEQ ID NO 1): MAGVAFNNGGLGLVHSISHQVGGVYKLQHGICNSVNM (SEQ ID NO 14).

[0046] In one embodiment the Mdh enzyme used in the recombinant methylotrophic strain comprises a sequence having at least 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 13 and / or comprising a sequence having at least 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 14, wherein said sequences, if both present in the polypeptide are spaced at least 40 residues apart, for example 40 to 50 or 40 to 45 residues apart.

[0047] In one embodiment the Mdh polypeptide comprises an N-terminal part having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to the N-terminal part containing amino acid residues 1-178 of Mdh Bm MGA3 (SEQ ID NO 1).

[0048] Initial experiments indicated that the N-terminal part of the Mdh enzyme may contribute to the enzyme's ability, or lack thereof, to overoxidize methanol into formate.

[0049] It was found that 24 highly conserved amino acid residues define the capability of Mdh enzyme to oxidize formaldehyde to formate. Mutation of these 24 residues in the non-overoxidizing enzyme Mdh Bm MGA3 (SEQ ID NO 1) resulted in a mutant enzyme Mdh Bm MGA3 mutant (SEQ ID NO 21) which gained the capacity to oxidize formaldehyde to formate, while maintaining its methanol oxidizing properties.

[0050] In one embodiment the heterogeneously expressed Mdh polypeptide therefore comprises the following amino acid residues:an aspartic acid (D) residue corresponding to the D70 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), an alanine (A) residue corresponding to the 72 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),ETHZ-37-PCTa glutamine (Q) residue corresponding to the Q75 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an isoleucine (I) residue corresponding to the 194 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glutamine (Q) residue corresponding to the Q120 residue in the homologousBacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a threonine (T) residue corresponding to the T136 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a leucine (L) residue corresponding to the L148 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a valine (V) residue corresponding to the V150 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a proline (P) residue corresponding to the P161 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an isoleucine (I) residue corresponding to the 1163 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an isoleucine (I) residue corresponding to the 1188 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S196 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an alanine (A) residue corresponding to the A204 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a lysine (K) residue corresponding to the K205 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a valine (V) residue corresponding to the V251 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glycine (G) residue corresponding to the G256 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S263 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S265 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glutamine (Q) residue corresponding to the Q275 residue in the homologousBacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),ETHZ-37-PCT- an isoleucine (I) residue corresponding to the 1278 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQID NO 1),- a serine (S) residue corresponding to the S281 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQID NO 1),- a methionine (M) residue corresponding to the M284 residue in the homologousBacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a leucine (L) residue corresponding to the L326 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), and- a methionine (M) residue corresponding to the M342 residue in the homologousBacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1).

[0051] These 24 amino acid residues distinguish the non-overoxidizing Mdh enzymes from the overoxidizing Mdh2 / Mdh3 class, with high conservation observed within each respective group.

[0052] The corresponding amino acid residues in the Mdh2 / Mdh3 class enzymes are:an asparagine (N) residue corresponding to the D70 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a threonine (T) residue corresponding to the A72 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an asparagine (N) residue corresponding to the Q75 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an isoleucine (I) residue corresponding to the 194 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a glutamic acid (E) residue corresponding to the Q120 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), an asparagine (N) residue corresponding to the T136 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), a phenylalanine (F) residue corresponding to the L148 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), an isoleucine (I) residue corresponding to the V150 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an alanine (A) or a valine (V) residue corresponding to the P161 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),ETHZ-37-PCTa valine (V) residue corresponding to the 1163 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an alanine (A) residue corresponding to the 1188 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a threonine (T) residue corresponding to the S196 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a serine (S) residue corresponding to the A204 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a threonine (T) residue corresponding to the K205 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a methionine (M) residue corresponding to the V251 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), an alanine (A) residue corresponding to the G256 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an alanine(A) residue corresponding to the S263 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an alanine (A) residue corresponding to the S265 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a proline (P) residue corresponding to the Q275 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a valine (V) residue corresponding to the 1278 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an alanine (A) residue corresponding to the S281 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),a leucine (L) residue corresponding to the M284 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),an isoleucine (I) residue corresponding to the L326 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), and a leucine (L) residue corresponding to the M342 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1).

[0053] It was found that the introduction of the 24 conserved amino acid residues of the Mdh2 / Mdh3 class enzyme into a non-overoxidizing Mdh enzyme (Mdh Bm MGA3;ETHZ-37-PCTSEQ ID NO 1) to obtain the variant Mdh Bm MGA3 mutant (SEQ ID NO 21) introduced the capacity to oxidize formaldehyde to formate. The non-overoxidizing enzyme was thus turned into an overoxidizing enzyme.

[0054] Conversely, these 24 highly conserved amino acid residues of the non-overoxydizing enzyme Mdh Bm MGA3 (SEQ ID NO 1) are thought to be sufficient to introduce non-overoxidizing behaviour, i.e. to significantly reduce or totally abolish the capacity to oxidize formaldehyde to formate, in a naturally overoxydizing Mdh enzyme.

[0055] The identified amino acid residues therefore together provide a key to turning an overoxidizing Mdh enzyme to a non-overoxidizing Mdh enzyme, and vice versa. By mutating these residues of an overoxidizing enzyme accordingly, the Mdh polypeptide is turned into a non-overoxidizing Mdh enzyme and as such adapted for heterologous expression in a recombinant non-naturally occurring methanol-dependent or fully methylotrophic microorganism according to this invention.

[0056] It was further found that in vitro addition of a Nudix hydrolase Act (SEQ ID NO 12) improved the oxidation of methanol catalyzed by a Mdh / Mdhl class enzyme but had no effect on the enzymes inability to further oxidize formaldehyde to formate.

[0057] In one embodiment, the recombinant methylotrophic microorganism of this invention therefore also expresses or over-expresses a polypeptide having a Nudix hydrolase Act (SEQ ID NO 12) activity.

[0058] In one embodiment the recombinant methylotrophic microorganism of this invention expresses or overexpresses all enzymes required for a complete ribulose monophosphate (RuMP) cycle. The microorganism thus expresses or over-expresses a polypeptide having methanol dehydrogenase activity, such as Mdh, a polypeptide having 3-hexulose 6-phosphate synthase, such as Hps, a polypeptide having 6-phospho 3-hexuloisomerase activity, such as Phi, a polypeptide having glucose-6-phosphate isomerase activity, such as Pgi, a polypeptide having transketolase activity, such as TktA, a polypeptide having ribulose-phosphate 3-epimerase, such as Rpe, a polypeptide having ribose-5-phosphate isomerase activity, such as RpiA, a polypeptide having transaldolase activity, such asTalA, a polypeptide having NADP+-dependent glucose-6-phosphate dehydrogenase, such as Zwf, a polypeptide having 2-keto-3-ETHZ-37-PCTdeoxygluconate 6-phosphate / 2-keto-4-hydroxyglutarate aldolase activity, such as Eda, and a polypeptide having a phosphogluconate dehydratase, such as Edd.

[0059] The recombinant non-naturally occurring methylotroph may be obtained by genetically modifying a non-naturally occurring methylotrophic bacterial organism selected from a group consisting of Escherichia, such as E. coli, Bacillus, such as B. subtilis, Clostridium, Enterobacter, Klebsiella, Mannheimia, Pseudomonas, such as P. putida, Acinetobacter, Shewanella, Paracoccus, Ralston!®, such as / ?. eutropha, Geabacter, Zymomonas, Acetobacter, Geabacilius, Lactococcus, Streptococcus, Lactobacillus, Corynebacterium, such as C. glutamicum, Streptomyces, Proprionibacterium, Synechocystis, Synechococcus, Cyanobacteria, Chlorobi, and Deinococcus.

[0060] In one embodiment the recombinant microorganism of this invention is a methanol-dependent strain. It may for example be a methanol-dependent E. coli strain, such as MDep_Ecoli having CCOS accession number CCOS 2133, or an E. coli strain having a doubling time and product profile of this strain.

[0061] In an alternative embodiment the recombinant microorganism of this invention is a fully methylotrophic strain, it may for example be a fully methylotrophic E. coli strain, such as the designated E. coli M Ful l_Ecoli having the CCOS accession number CCOS 2146, the designated E. coli MEcoli_ref_l having CCOS accession number CCOS 2032, the designated E. coli MEcoli_ref_2 having CCOS accession number CCOS 2080, the designated E. coli strain SMI having ATCC accession number PTA-126783, or an E. coli strain having a doubling time and product profile of CCOS deposit accession number CCOS 2032, of CCOS deposit accession number CCOS 2080, or of ATCC accession number PTA-126783.

[0062] The invention also concerns a variant polypeptide of a Mdh polypeptide, for example an Mdh polypeptide classified as an Mdh2 / Mdh3 class enzyme, which has been modified such that its VmaxCHzO determined as described herein is less than 1, or less than 0.1, or is 0. The variant polypeptide comprises at least one or more amino acid substitutions, deletions and / or insertions of its reference polypeptide sequence.ETHZ-37-PCT

[0063] The variant polypeptide may be a variant of an overoxidizing parentai enzyme which has through mutation acquired the required non-overoxidizing properties, as defined by its VmaxCHzO.

[0064] The variant polypeptide may be a variant of an Mdh poiypeptide having at ieast 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to Mdh2 Bm MGA3 (SEQ ID NO 7).

[0065] The variant may for example comprise the 24 conserved amino acid residues of the Mdh Bm MGA3 enzyme (SEQ ID NO 1) mentioned above, which have been associated with non-overoxidizing behaviour of Mdh enzymes. A variant polypeptide having Mdh activity may comprise an N-terminal part with at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to the N-terminal comprising amino acid residues 1-178 of Mdh Bm MGA3 (SEQ ID NO 1).

[0066] According to this invention a variant polypeptide having Mdh activity may comprise a sequence having at least 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 13 and / or comprising a sequence having at least 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 14, wherein said sequences, if both present in the polypeptide are spaced at least 40 residues apart, for example 40 to 50 or 40 to 45 residues apart. One or both of said sequences may be comprised in the C-terminal part of the Mdh polypeptide, corresponding to amino acid residues 181 - 382 of Mdh Bm MGA3 (SEQ ID NO 1).

[0067] The invention also concerns an expression vector or a cell comprising nucleotide sequences encoding for these variant Mdh polypeptides.

[0068] The invention further concerns a method for producing or for increasing production of a microbial metabolite or product. For this purpose, the recombinant non-naturally occurring methylotroph microorganism of this invention is grown on a Cl compound, for example methanol. The microorganism converts the Cl compounds into microbial metabolites or products which are subsequently retrieved from the culture.ETHZ-37-PCT

[0069] Depending on the genotype of the strain and the growth conditions, different metabolites or products may be obtained.

[0070] Such metabolites or products may for example be one or more of 2-carbon compounds; 3-carbon compounds, such as lactate, or lactic acid; 4-carbon compounds, such as isobutanol, butanol, or 1,4-butanediol; 5-carbon compounds, such as n-pentane, glutamate; higher carboxylic acids, alcohols of higher carboxylic acids; polyhydroxyalkanoates, such as polyhydroxybutyrate (PHB); taxadiene; itaconate; speciality chemicals; aromatic compounds; vitamins; derivatives or precursors of vitamines; carotenoids; amino acids; and sugars, such as deoxyriboseDefinitions

[0071] A "recombinant" microorganism refers to a microorganism which has been genetically modified to express or over-express endogenous nucleotide sequences, or to express non-endogenous nucleotide sequences, such as those included in a plasmid, or which has a reduction in expression of an endogenous gene. In analogy, a "recombinant" polypeptide is a polypeptide created through a genetically modified nucleotide sequence of a gene.

[0072] A "synthetic" microorganism refers to a recombinant microorganism in which a portion of the genome or the entire genome has been genetically modified.

[0073] A "non-naturally occurring methylotrophic microorganism" refers to a microorganism derived from an ancestral microorganism which lacks the ability of methylotrophic growth, but through recombinant engineering or recombinant engineering and laboratory evolution has been adapted to methylotrophic growth.

[0074] The term "recombinant methylotroph" as used herein refers to a non-naturally occurring genetically modified methylotroph.

[0075] A "methylotrophic" microorganism, also referred to as "methylotroph", is a microorganism which converts Cl compounds, in particular methanol, into biomass. A methylotrophic microorganism may be a "methanol-dependent" microorganism or a "fully methylotrophic" microorganism.ETHZ-37-PCT

[0076] The term "methanol-dependent" microorganism refers to a microorganism which requires methanol as well as other multi-carbon substrates for growth. Even though this microorganism requires methanol for growth, it is unable to grow on Cl compounds as sole carbon source. It requires methanol to grow on certain multicarbon sources such as pyruvate in the absence of methanol. " Methanol-dependent" therefore indicates the requirement for methanol and at least one multi-carbon compound for growth.

[0077] The term "fully methylotrophic" microorganism is a microorganism which uses exclusively reduced Cl compounds as carbon source. Preferably, the main Cl carbon source for a methylotroph is methanol. " Fully methylotroph" or "full methylotrophy" therefore indicate that only Cl-compounds, in particular methanol, are required as carbon substrates for growth.

[0078] A "chimeric polypeptide" is a polypeptide created through the joining of two or more genes which are originally coded for separate or same polypeptides or regions of polypeptides.

[0079] A "variant polypeptide" is a polypeptide comprising an amino acid sequence having at least 70% or at least 80% sequence identity to a reference polypeptide and differing therefrom by one or more amino acid substitutions, deletions and / or insertions. The variant polypeptide may differ from the reference polypeptide over its full length or over one or more defined regions thereof, for example an N-terminal and / or a C-terminal region. The variant polypeptide may further be a chimeric polypeptide comprising regions derived from two or more reference polypeptides.

[0080] The singular "a", "an" and "the" include the plural equivalents unless the context distinctly indicates otherwise.

[0081] The terms "comprises" and "contains" denote "includes" in a non-limiting sense, while the term "consisting" indicates a limiting sense.

[0082] The terms "e.g.", "for example" and "such as" as used herein denote specific non-limiting examples that fall under a more general category.ETHZ-37-PCTShort description of the drawings

[0083] Exemplar embodiments of the invention are disclosed in the description and illustrated by the drawings in whichFigure 1A shows a growth curve (Optical density (OD600)) and formate production of the methanol-dependent strain AfrmAAtpiA expressing mdh, hps, and phi (strain MDep_Ecoli) during growth on methanol (500 mM) and pyruvate (20 mM) in shake flasks (n = 3), with shaded region representing the range of the 95% confidence interval;Figure IB depicts a simplified metabolic scheme illustrating methanoldependent growth of MDep_Ecoli when cultivated on methanol and pyruvate, with molecules originating from formaldehyde or close to the one-carbon entry point being expected to be formed from methanol (black section of cycle) while others being formed from pyruvate (gray section of cycle), and the canonical formaldehyde detoxification pathway of E. coli, which is inactivated in MDep_Ecoli due to its frmA deletion, being indicated by the dashed line;Figure 1C is a bar chart showing fractions of formate molecules determined in the supernatant of the MDep_Ecoli originating from13C methanol (white) and12C pyruvate (black) when sampled at stationary phase, with R1 to R4 indicating replicate experiments;Figure 2A to 2C show results from in vitro assays of Mdh2 CT4-1 Cn showing the change in NADH concentration by monitoring the absorption at 340 nm, with reaction mixtures containing 12.3 pM enzyme, 5 mM NAD+and reactions being started by the addition of 500 mM formaldehyde (Figure 2A) or methanol (Figure 2B), with shaded regions representing the range of 90% confidence interval; and Figure 2C summarizes Vmax values determined by in vitro assays for 10, 20, 50, 100 and 500 mM methanol or formaldehyde as initial concentrations, with methanol to formaldehyde reactions are indicated as dots, formaldehyde to formate indicated as crosses, and error bars representing the standard deviation (n = 4 for 500 mM formaldehyde, n = 3 for remaining conditions);ETHZ-37-PCTFigure 3A shows formate production by different NAD-dependent methanol dehydrogenases, with strains overproducing Mdh in E. coli Screen_Ecoli (AfrmRAB) being grown on methanol (500 mM) and pyruvate (20 mM) and formate being quantified in the supernatant of the cultures after 69 h, whereby the formate levels of a strain harboring an empty plasmid were used as background control and subtracted from each measured value, and error bars represent the standard deviation (n = 3);Figure 3B shows a phylogenetic clustering presentation based on multiple sequence alignment and phylogenetic analysis of Mdh enzymes, which revealed that Mdh enzymes which overoxidize methanol to produce formate are phylogenetically distinct from Mdh enzymes which do not overoxidize methanol and are found in the Mdh / Mdhl class shown by the box;Figures 4A and 4B show in vitro assays of Mdh Bm MGA3 activity with changes in NADH concentration (absorption at 340 nm) as read-out for enzymatic activity, with reaction mixtures containing 12.5 pM Mdh Bm MGA3, 5 mM NAD+and reactions being started by adding 500 mM formaldehyde (Figure 4A) or methanol (Figure 4B), respectively, wherein shaded regions represent the range of the 90% confidence interval;Figure 4C presents a summary of Vmax determined by in vitro assays for 5, 10, 20, 50, 100 and 500 mM methanol and formaldehyde as initial concentrations, with methanol to formaldehyde reactions are indicated as dots, formaldehyde to formate indicated as crosses, with error bars representing the standard deviation (n = 3);Figures 5A to 5L show in vitro assays of Mdh activity with changes in NADH concentration (absorption at 340 nm) as read-out for enzymatic activity, with Mdh Bm MGA3 activity indicated by a solid line and overoxidizing Mdh2 CT4-1 Cn activity indicated by an dashed line, with reaction mixtures containing 12.3 (Mdh2 CT4-1 Cn) or 12.5 pM (Mdh Bm MGA3) of the respective enzyme, 5 mM NAD+and reactions being started by adding 5, 10, 20, 50, 100, or 500 mM methanol or formaldehyde, as indicated, with shaded regions representing theETHZ-37-PCTrange of the 90% confidence interval; all experiments were performed in triplicates;Figures 6A and 6B show the results of in vitro assays of Mdh Bm MGA3 activity with changes in NADH concentration (absorption at 340 nm) as read-out for enzymatic activity at 37 °C and 50 °C in the presence (dashed line) or absence (solid line) of the activator protein Act Bm, with Figure 6A showing Mdh Bm MGA3 activity with methanol as a substrate, and Figure 6B showing Mdh Bm MGA3 activity with formaldehyde as a substrate, with reaction mixtures containing 3.1 pM Mdh, 2.3 pM Act, 5 mM NAD+and being started by adding 500 mM methanol or 2 mM formaldehyde, respectively;Figure 7A shows changes In NADH levels of in vitro assays of Mdh2 CT4-1 Cn (solid line), Mdh Bm MGA3 (dashed line), and Mdh Bm MGA3 with Act (dotted line) monitored until equilibrium was reached, with reaction mixtures containing 25 pM Mdh2 CT4-1 Cn or 25 pM Mdh Bm MGA3, 2.3 pM Act if indicated, 5 mM NAD+and reactions being started by adding 500 mM methanol;Figure 7B shows the two oxidation steps catalysed by Mdh enzymes of the Mdh2 / Mdh3 group, with a first oxidation step from methanol to formaldehyde and a second oxidation step from formaldehyde to formate; ArG'0 values were calculated by eQuilibrator (pH = 7.4, pMg = 2.3, ionic strength = 0.15 M);Figure 7C shows equilibrium concentrations of formaldehyde, formate, and NADH with reaction mixtures containing 25 pM of the respective enzyme, 5 mM NAD+and reactions being started by adding 500 mM methanol; all experiments were performed in triplicates;Figures 8A and 8B show growth curves (optical density at 600 nm) (dashed line) and formate production (solid line) of methanol-dependent strain (hfrmAhtpiA) expressing the non-overoxidizing mdh Bm MGA3 (MDep_Ecoli) (Figure 8A) or the overoxidizing mdh2 CT4-1 Cn (Figure 8B) during growth on methanol (500 mM) and pyruvate (20 mM) (n = 3), with shaded region representing the range of the 95% confidence interval;ETHZ-37-PCTFigures 9A, 9B, 9C show the methanol (Figure 9A), formaldehyde (Figure 9B) and formate (Figure 9C) concentration in the supernatant of whole cell assays on BL21-Gold (DE3) frmA strains, each expressing a different methanol dehydrogenase enzyme (Mdh2 CT4-1 Cn (overoxidizing control), Mdh Bm MGA3 (non-overoxidizing control), Chimera 1 (N-terminal part of Mdh Bm MGA3 (amino acids 1-178) linked with MV to C-terminal part of Mdh2 CT4-1 Cn (amino acids 189-390), Chimera 2 (N-terminal part of Mdh2 CT4-1 Cn (amino acids 1-186) linked with MV to C-terminal part of Mdh Bm MGA3 (amino acids 181-382). Pyruvate kinase 1 (PykF) was used as negative control. Whole cell assays were started with 800 mM13C methanol and metabolites were quantified in the supernatant after 10 h. Error bars represent the standard deviation of three replicates.Figures 10A and 10B show in vitro assays of Chimera 1 (N-terminal site Mdh Bm MGA3 and C-terminal site Mdh2 CT4-1 Cn) activity with changes in NADH concentration (absorption at 340 nm) as read-out with reaction mixtures containing 126.5 pM enzyme, 5 mM NAD+and reactions being started by adding 800 mM methanol (Figure 10A) or 5 mM formaldehyde (Figure 10B), as indicated, with shaded regions representing the range of the 90% confidence interval; experiment started from methanol were performed in duplicates and from formaldehyde in triplicates;Figure 11 shows a growth curve of strain M Ful l_Ecol i expressing non-overoxidizing Mdh B. methanolicus MGA3 on methanol as its sole carbon and energy source, with experiments performed in nonuplicates, and the mean data shown as dashed line, the shaded region representing the range of 95% confidence interval;Figure 12A shows itaconic acid production (dashed line) and formate side production (solid line) by strain MEcoli_ref_2 utilizing the overoxidizing Mdh2 CT4-1 Cn for growth on methanol and containing the itaconic acid production plasmid pljta (SEQID NO 19);Figure 12B shows itaconic acid production (dashed line) and formate side production (solid line) by strain MFull_Ecoli utilizing the non-overoxidizing MdhETHZ-37-PCTB. methanolicus MGA3 for growth on methanol and containing the itaconic acid production plasmid pljta (SEQ ID NO 19);Figure 13 shows lactic acid production and formate side production by strain MEcoli_ref_2 utilizing the overoxidizing Mdh2 C. necator for growth on methanol and containing the lactic acid production plasmid pljac SEQ ID NO 20);Figures 14A, 14B and 14C show in vitro assays of the Mdh Bm MGA3 (WT) and Mdh Bm MGA3 mutant (SEQ ID NO 21) activity with changes in NADH concentration (absorption at 340 nm) as read-out at 50 °C with reaction mixtures containing 10 pM Mdh enzyme, 1 pM Act, 5 mM NAD+and reactions being started by adding 50 mM formaldehyde (Figure 14A) or 800 mM methanol (Figure 14B, 14C), as indicated, with the black solid (Mdh Bm MGA3 mutant) or dotted (Mdh Bm MGA3) lines representing the mean and the grey lines representing the standard deviation; experiments were performed in triplicates for Mdh Bm MGA3 mutant (SEQ ID NO 21) and Mdh Bm MGA3 (SEQ ID NO 1) (with methanol) or duplicates Mdh Bm MGA3 (with formaldehyde); andFigure 15 depicts a sequence alignment of non-overoxidizing Mdh enzymes (Mdh Bm MGA3 (SEQ ID NO 1), Mdh Bm PB1 (SEQ ID NO 2), Mdhl Bm PB1 (SEQ ID NO 3)), and overoxidizing Mdh enzymes (Mdh2 Bm MGA3 (SEQ ID NO 7), Mdh3 Bm MGA3 (SEQ ID NO 8), Mdh2 Bm PB1 (SEQ ID NO 9), Mdh2 CT4-1 Cn (SEQ ID NO 10), Mdh Lx (SEQ ID NO 11)), with the dashed box indicating the NAD-binding site, with the solid line boxes 1 and 2 indicate regions which are enriched in distinguishing residues, containing the metal ion binding site, with conserved residues of the overoxidizing enzymes shown in bold, and the 24 distinguishing residues involved in overoxidation indicated with triangles.ETHZ-37-PCTExamples of embodiments of the present invention

[0084] The genes mdh Bm MGA3 and mdh Bm PB1 are essential for methylotrophy in their native hosts Bacillus methanolicus. They are expressed from a multi-copy endogenous plasmid and the encoded Mdh enzymes constitute up to 22% of the proteome in the natural methylotrophic B. methanolicus strains MGA3 and PB1.

[0085] The gene mdhl Bm PB1 also belongs to the Mdh / Mdhl class but is expressed from the genome. The genomes of B. methanolicus strains MGA3 and PB1 also contain genes encoding Mdh enzymes that were previously categorized as Mdh2 / Mdh3 type enzymes.

[0086] Even though it was known previously that Mdh enzymes can phylogenetically be categorised in two distinct classes or clusters, the significance of these classes was previously not recognized. The separation of Mdhs into two classes was based on their respective amino acid sequences, which are at least 30% different. Similar in vitro activity on methanol had previously been reported for the Mdh / Mdhl and Mdh2 / Mdh3 type enzymes and the physiological relevance of their difference remained unclear. In other words, no particular phenotypic feature distinguishing between the two classes had been identified.ic E. coli accumulate formate as a side-

[0087] Formate accumulation was for example observed by the previously reported recombinant fully methylotrophic E. coli strain MEcoli_ref_2 (W02024018304A1) when grown on methanol. When grown in a bioreactor on methanol, formate was produced in the mM range (~ 3 mM, 138 mg L-1). Even higher concentrations of formate, up to 38 mM, accumulated during the production of itaconic acid or lactic acid from methanol. In each of the production batches, formate was produced in excess of the intended product (2-fold excess in molar concentration for lactic acid production and up to 37-fold excess in molar concentration for itaconic acid production).ETHZ-37-PCT

[0088] To examine whether formate production was a result of the adaptive laboratory evolution (ALE) over approximately 1200 generations this fully methylotrophic E. coli strain MEcoli_ref_2 had been subjected to, formate production of its ancestral strain, which is a methanol-dependent strain (AfrmAAtpiA) heterologously expressing mdh, hps, and phi, was tested in the same experimental setup. The ancestral strain also produced formate (~ 8 mM) (Figure 1A), indicating that formate generation is intrinsic to the strain rather than the result of ALE toward fully methylotrophic growth.

[0089] Synthetic constructs were used for heterologous expression of Mdh2 CT4-1 Cn (pSEVA434_mdh2_CT4-1_Cn, SEQ ID NO 23), and of Hps and Phi proteins (pSEVA131_hps_phi_Mf, SEQ ID NO 16).

[0090] The metabolic origin of formate production in absence offrmA, which encodes a key enzyme of the formaldehyde detoxification pathway, formaldehyde-dependent S-(hydroxymethyl)glutathione dehydrogenase, was however not well understood.

[0091] One potential mechanism for formate generation could be the activity of an alternative dehydrogenase that compensates for the lack o f rm A in the strain. To investigate this, the entire formaldehyde detoxification pathway operon (AfrmRAB) was deleted in the ancestral strain, resulting in strain Screen_Ecoli. However, the deletion of the entire operon did not result in a reduction of formate production which points to a different route for formate production by the methylotrophic E. coli strain.

[0092] It was speculated that formate originates from a metabolite close to the one-carbon entry point into the RuMP cycle. To test this hypothesis the ancestral methanol-dependent strain was grown under defined conditions in which overall carbon flux from methanol and pyruvate is well characterized and consistent with flux balance analysis. By feeding13C labelled methanol and unlabelled pyruvate, the origin of formate was traced on the basis of its labelling pattern (Figure IB). The results revealed that more than 95% of the formate originated from methanol (Figure 1C), indicating that the formate produced by the strain derives from either formaldehyde or a RuMP cycle intermediate close to the one-carbon entry point.ETHZ-37-PCT

[0093] Since the methanol dehydrogenase (Mdh) is one of the three heterologously expressed enzymes in recombinant methylotrophic strains, it was a possible candidate for driving the production of formate, possibly through direct oxidation of formaldehyde, which is the product of the Mdh catalysed oxidation of methanol, to formate.

[0094] It was therefore tested whether this enzyme could catalyse both reactions, i.e. the oxidation from methanol to formaldehyde, as well as the oxidation of the formaldehyde to the obtained formate product, thereby preventing formaldehyde from being metabolized through the RuMP cycle. In aqueous solution, formaldehyde exists predominantly as methylene glycol. It was speculated methylene glycol could possibly be recognized as a substrate by Mdh.NAD-dependent methanolMdh2 CT4-1 Cn oxidizes formaldehyde to formate in vitro

[0095] To test this hypothesis, the Mdh enzyme Mdh2 CT4-1 Cn (SEQ ID NO 10), which is the heterologously introduced methanol dehydrogenase in the methanol-dependent ancestral strain and its descendant methylotrophic strains MEcoli_ref_l and MEcoli_ref_2 (W02024018304A1). The Mdh2 CT4-1 variant used in this study (SEQ ID NO 10) contains point mutations A26V, A31V, A169V compared to the wild-type Mdh2 CT4-1 enzyme.

[0096] To investigate whether Mdh2 CT4-1 Cn oxidizes formaldehyde to formate, the enzyme was purified from an E. coli BL21-Gold (DE3) overexpression culture and characterized in vitro. NADH formation was monitored upon addition of 500 mM formaldehyde to a reaction mixture containing 12.3 pM Mdh and 5 mM NAD+, and buffer at 37 °C.

[0097] NAD+reduction to NADH was observed immediately after the addition of formaldehyde (Figure 2A), confirming that the enzyme catalyzes the oxidation of formaldehyde to formate. As expected, NADH formation was also observed when the reaction was started from methanol (Figure 2B). Further experiments at varying substrate concentrations revealed that formaldehyde oxidation proceeds with substantially higher turnover rates than methanol oxidation (Figure 2C).ETHZ-37-PCT

[0098] These findings demonstrate that Mdh2 CT4-1 Cn overoxidizes methanol to formate and suggest that Mdh is responsible for formate production by synthetically methylotrophic E. coli strains.Overoxidation of methanol by NAD-dependent methanol dehydrogenases is common

[0099] To examine whether overoxidation is a general feature of NAD-dependent Mdh, nine different NAD-dependent Mdhs were overexpressed in an E. coli strain Screen_Ecoli lacking the canonical formaldehyde detoxification pathway (AfrmRAB). When grown on methanol and pyruvate, six of the tested Mdh enzymes produced between 4 mM and 14.5 mM formate, whereas the three other enzymes others produced only minor levels of less than 0.5 mM of formate (Figure 3A).

[0100] The Mdh enzymes producing formate from methanol by a two-step oxidization of methanol to formaldehyde and subsequently of formaldehyde to formate, are herein referred to as overoxidizing enzymes. In contrast, the Mdh enzymes which are catalysing the first oxidation step, i.e. the oxidation of methanol to formaldehyde, only, are herein referred to as non-overoxidizing enzymes.

[0101] Multiple sequence alignment and phylogenetic analysis revealed that the non-overoxidizing enzymes form a separate class, sharing less than 70% sequence identity with the remaining enzymes (Figure 3B). This class has previously been described as the Mdh / Mdhl in B. methanolicus strains (Krog et al; PLoS ONE 8, (2013), DOI: 10.1371 / journal. pone.0059188), where these enzymes represent the predominant methanol dehydrogenase in these organisms. The physiological relevance of the enzyme class had however previously not been identified.

[0102] The results obtained in this study revealed a distinct catalytic activity of the Mdh / Mdhl class compared to other bacterial methanol dehydrogenases. This is the first evidence for a potential difference in function of NAD-dependent methanol dehydrogenases in methanol physiological pathways. The observed non-overoxidation of methanol of the Mdh / Mdhl class, in contrast to other Mdh enzymes, may be the key characteristic of this class of Mdh enzymes.ETHZ-37-PCT

[0103] Based on these results it is postulated that NAD-dependent methanol dehydrogenases (Mdh) fall in two groups, which are a first group of overoxidizing enzymes, converting methanol to formate, and a second group of non-overoxidizing enzymes, oxidizing methanol to formaldehyde, but not catalysing the second oxidation step of formaldehyde to formate. Mdh enzymes of this second group form part of the phylogenetic Mdh / Mdhl class.Mdh Bm MGA3 does not oxidize formaldehyde in vitro

[0104] The in vivo Mdh screen resulted in the identification of three candidate methanol dehydrogenases that do not overoxidize methanol to formate in vivo. To further validate this property, one of these three enzymes, Mdh Bm MGA3 (SEQ ID NO 1), was purified from an E. coli BL21-Gold (DE3) overexpression culture for in vitro assays.

[0105] In contrast to Mdh2 CT4-1 Cn, which does not form part of the Mdh / Mdhl phylogenetic cluster of Mdh enzymes, no NADH was detected in the in vitro Mdh activity assay using Mdh Bm MGA3 when formaldehyde (500 mM) was used as a substrate. This result demonstrates that Mdh Bm MGA3, which is one of the Mdh / Mdhl enzymes, does not oxidize formaldehyde (Figure 4A), confirming the in vivo results for this enzyme.

[0106] When starting the reaction with the same concentration of methanol, NADH formation was observed (Figure 4B). In comparison to Mdh2 CT4-1 Cn, the turnover rate for the oxidation of methanol by Mdh Bm MGA3 was about 7 times slower, which is in line with previous reports due to the inferior catalytic efficiency in the absence of Act and difference in temperature optimum of Mdh Bm MGA3. To avoid a potential inhibitory or inactivating effect of a high concentration formaldehyde, which had been provided at 500 mM, lower initial formaldehyde concentrations were also tested. Interestingly, over a range of 5 mM to 500 mM of formaldehyde, Mdh Bm MGA3 showed no observable oxidation activity (Figure 4C, Figures 5B, D, F, H, J, and L, solid lines). In contrast, the Mdh2 / Mdh3 type enzyme Mdh2 CT4-1 Cn showed rapid oxidization of formaldehyde over the whole range of concentrations (Figures 5B, D, F, H, J, and L, dashed lines).ETHZ-37-PCT

[0107] Data from initial experiments seemed to suggest that Mdh2 CT4-1 Cn has a higher turnover rate than Mdh Bm MGA3 when methanol is provided as a substrate, as shown in Figures 5A, C, E, G, I and K), in particular at concentrations of 50 mM and above. However, this difference could not be confirmed when Nudix hydrolase Act (SEQ ID NO 12) was added to the assay mixture. In the presence of Act, the overoxidizing Mdh2 CT4-1 Cn enzyme and the non-overoxidizing Mdh Bm MGA3 enzyme had comparable turnover rates for the methanol substrate, with the Mdh Bm MGA3 enzyme catalyzing the oxidization of methanol more rapidly (data not shown).in vitro in the presence of a Nudix

[0108] NAD-dependent methanol dehydrogenases are known to be activated by Nudix hydrolases, resulting in superior catalytic efficiency in vitro. To investigate whether the activation activity of the Nudix hydrolase Act of B. methanolicus could in any way serve to overcome the lack of ability of Mdh Bm MGA3 to oxidize formaldehyde, Act was purified from a BL21-Gold (DE3) E. coli overexpression culture and the formaldehyde oxidization assay using Mdh Bm MGA3 was repeated the in vitro assay in the presence of Nudix hydrolase Act.

[0109] As shown in Figure 6B, no NADH was generated when the reaction was started with formaldehyde in the presence of Act, regardless of whether the assay was performed both at the optimal growth temperature of E. coli (37 °C) or that of B. methanolicus (50 °C), indicating that no oxidation of formaldehyde in the assay occurred. In contrast, when methanol was provided as a substrate for Mdh Bm MGA3, the Nudix hydrolase Act greatly increased oxidation activity of the Mdh enzyme regardless of whether the reaction was performed at 37 °C or at 50 °C (Figure 6A).micilibrium anavalidate non-overoxidizing Mdh

[0110] To learn more about the respective enzymatic activities of overoxidizing enzymes, for example Mdh2 / Mdh3 type enzymes, compared to non-overoxidizing Mdh / Mdhl type enzymes, the equilibrium states of the in vitro reactions for Mdh2 CT4-1 Cn, an overoxidizing enzyme, and Mdh Bm MGA3, a Mdh / Mdhl type enzyme, were compared. In these experiments, 500 mM methanol, 5 mM NAD+, and 25 pMETHZ-37-PCTMdh were incubated until equilibrium was reached. The enzymatic activity of Mdh Bm MGA3 was also tested in the presence of Act.

[0111] The time to reach equilibrium varied substantially between the different reactions, with Mdh Bm MGA3 in the presence of Act requiring the shortest time due to the higher catalytic activity (Figure 7A).

[0112] In addition, it was found that metabolite concentrations at equilibrium differ between overoxidizing Mdh2 CT4-1 Cn and non-overoxidizing Mdh Bm MGA3. Consistent with the hypothesis of one versus two-step oxidation process (methanol to formaldehyde, and formaldehyde to formate), the final NADH levels differed markedly between the overoxidizing and non-overoxidizing Mdh enzymes (900 pM versus 140 pM formed NADH), irrespective of Act addition.

[0113] Thermodynamic calculations based on the Gibbs free energy under standard conditions for methanol oxidation to formaldehyde (AGr'0 = 32.0 ± 6.5 kJ / mol) and formaldehyde oxidation to formate (AGr'0 of -49.6 ± 3.8 kJ / mol) (Figure 7B) predicted roughly 100 pM for the non-overoxidizing reaction under the experimental conditions, closely matching the observed value (Figure 7C).

[0114] For an overoxidizing Mdh, the calculated NADH concentration was close to 5 mM which is higher than what was measured (920 pM). Similarly, measured formaldehyde and formate concentrations at equilibrium deviated from theoretical values in the overoxidizing reaction (57 pM vs 0.01 pM formaldehyde and 368 pM vs 2.5 mM formate), suggesting constraints such as limited affinity for formaldehyde or incomplete equilibration within the experimental timeframe. These results further support the initial findings regarding the inability of Mdh Bm MGA3 to oxidize formaldehyde.reduces the accumulation of formatemethanol-i

[0115] The in vivo and in vitro experiments described above showed that Mdh Bm MGA3, unlike overoxidizing Mdh enzymes, does not oxidize formaldehyde. This finding identifies Mdh / Mdhl-type enzymes as promising candidates for previouslyETHZ-37-PCTreported synthetically methylotrophic E. coli strains, in which only overoxidizing Mdh enzymes have been introduced and utilized so far.

[0116] To address the problem of unwanted production of formate by these synthetic methylotrophs, this invention therefore provides methanol-dependent and fully methylotrophic strains expressing Mdh / Mdhl type enzymes instead of the previously used overoxidizing Mdh enzymes, thereby reducing or preventing the accumulation of formate. As a further important aspect, the use of Mdh / Mdhl type enzymes in synthetic methylotrophs also serves to maintain a steady pool of formaldehyde for assimilation purposes, since formaldehyde is not further oxidized to formate.

[0117] To further confirm the efficacy of the proposed solution, it was tested whether a non-overoxidizing Mdh is sufficient to sustain growth of E. coli in the presence of methanol without causing the accumulation of formate.

[0118] For this purpose, the non-overoxidizing mdh genes (mdh Bm MGA3) in addition to the RuMP cycle genes hps and phi was introduced into the AfrmAAtpiA background to generate two different strains expressing mdh Bm MGA3. Methanoldependent growth has the advantage that it can be readily established due to the lower biomass contribution of methanol. The two strains were adapted for methanoldependent growth as previously described for mdh2 CT4-1 Cn (Keller, P. et al.; Nat. Commun. 11, 5403 (2020), DOI: 10.1038 / s41467-020-19235-5) to generate two distinct methanol-dependent strains. Strikingly, 8 times lower amounts of formate (Figure 8A) as for the methanol-dependent strain expressing mdh2 CT4-1 Cn (Figure 8B) was observed for the strain expressing mdh Bm MGA3.

[0119] These results demonstrate that methanol-dependent growth of E. coli using a non-overoxidizing Mdh, in this case Mdh Bm MGA3, is possible and that formate accumulation is drastically reduced in this strain. The replacement of Mdh also indicates that overoxidation of methanol by Mdh2 CT4-1 Cn was responsible for formate accumulation in previously described synthetically methylotrophic E. coli strains which expressed this overoxidizing enzyme.ETHZ-37-PCT

[0120] In order to assess if fully methylotrophic growth was possible when the recombinant strain expresses a non-overoxidizing Mdh enzyme as opposed to the previously reported overoxidizing Mdh enzyme, a fully methylotrophic E. coli strain was cured from its plasmids and retransformed with a plasmid for expressing the non-overoxidizing mdh Bm MGA3, hps and phi M.flagellatus genes(pSEVA131_mdh_Bm_MGA3_hps_Mf_phi_Mf; SEQ ID NO 22). Growth performance of this strain was improved by serial dilution resulting in strain MEcoli_Full and then assessed using a medium containing methanol as sole source or carbon and energy.

[0121] The growth of the strain on this medium to an ODeoo of up to 7.5 as shown in Figure 11 clearly demonstrates that fully methylotrophic growth of a recombinant microorganism is achievable when a non-overoxidizing Mdh enzyme is used for methanol assimilation in place of an overoxidizing enzyme.of itaconic acid with minimal formate sideformation

[0122] The fully methylotrophic strain MFu ll_Ecoli expressing non-overoxidizing Mdh Bm MGA3 was further transformed with the itaconic acid production plasmid pljta (SEQ ID NO 19) to introduce the ability to generate itaconic acid from the assimilated carbon.

[0123] As a control, the strain MEcoli_ref_2 expressing the overoxidizing Mdh2 CT4-1 Cn enzyme was also transformed with the pljta production plasmid and the concentrations of the itaconic acid product as well as the formate side product was determined in the growth supernatants of these strains.

[0124] It was found that the concentration of the formate side product largely exceeded the itaconic acid concentration in the growth supernatant of the strain expressing the overoxidizing Mdh enzyme Mdh2 CT4-1 Cn, as shown in Figure 12A. Replacement of this overoxidizing enzyme by the non-overoxidizing enzyme Mdh Bm MGA3 drastically reduced the amount of formate detected in the growth supernatant, as shown in Figure 12B.ETHZ-37-PCT

[0125] When the strain expressing the overoxidizing Mdh enzyme Mdh2 CT4-1 Cn was used for lactic acid production, expressing the relevant enzymes from plasmid pljac (SEQ ID NO 20), the amount of formate produced was almost twice as high as produced the lactic acid, as shown in Figure 13.

[0126] These results confirm the ability of a recombinant strain of this invention, expressing a non-overoxidizing Mdh enzyme instead of an overoxidizing Mdh enzyme, to drastically decrease the formation of the formate side product during production of the desired carbon products. A reduction of the contaminant formate during production renders the process more efficient and improves its scalability.N-terminal part of Mdhinfluences overoxidation

[0127] To evaluate the regions of the Mdh enzyme which determine the enzyme's ability of oxidize formaldehyde, chimeric Mdh proteins were generated.

[0128] A first chimera (Chimera 1, SEQ ID NO 17) contained the C-terminal part (amino acids 189-390) of Mdh2 CT4-1 Cn and the N-terminal part (amino acids 1-178) of Mdh Bm MGA3 (non-overoxidizing N-terminal part). The two parts were linked with an overlapping sequence of two amino acids (MV) which is present in both enzymes. A second chimera (Chimera 2, SEQ ID NO 18) contained the C-terminal part (amino acids 181-382) of Mdh Bm MGA3 (non-overoxidizing C-terminal part) and the N-terminal part (amino acids 1-186) of Mdh2 CT4-1 Cn. Both parts were linked with an overlapping sequence of two amino acids (MV) which is present in both enzymes.

[0129] A whole cell assay was performed on the two chimera proteins, in which the chimeras were overexpressed in a BL21-Gold (DE3) AfrmA strain (Figures 9A, 9B, 9C). Mdh Bm MGA3 was used as non-methanol-overoxidizing control, Mdh2 CT4-1 Cn as methanol overoxidizing control. Chimera 1 produced low amounts of formaldehyde (Figure 9C) while not producing formate (Figure 9B), indicating that the N-terminal part of Mdh Bm MGA3 is important for the absence of overoxidation. Chimera 2 activity was not detected.

[0130] The absence of overoxidation by Chimera 1 was confirmed by purifying it and testing it in vitro. As seen in the whole cell assay, activity for the catalysis of theETHZ-37-PCTreaction of methanol to formaldehyde was detected (Figure 10A), while no activity was observed for the reaction from formaldehyde to formate (Figure 10B).

[0131] A sequence alignment of three non-overoxidizing Mdh enzymes (Mdh Bm MGA3, Mdh Bm PB1, Mdhl Bm PB1), belonging to the Mdh / Mdhl class enzymes, and five overoxidizing Mdh enzymes (Mdh2 Bm MGA3, Mdh3 Bm MGA3, Mdh2 Bm PB1, Mdh2 CT4-1 Cn, Mdh Lx), belonging to the Mdh2 / 3 class enzymes, is shown in Figure 15. The box with a dashed line indicates the position of the NAD-binding site in these enzymes. The solid line boxes 1 and 2 residues which are either part of or in proximity to the active site.

[0132] Interestingly, the conserved sequences of boxes 1 and 2 differ considerably between the Mdh / Mdhl class and the Mdh2 / 3 class of the Mdh enzmyes. Without wishing to be bound by any particular hypothesis, it was speculated that these conserved regions may play a role in the enzyme's ability to oxidize formaldehyde to formate, potentially contributing to this function.

[0133] In particular, conserved region 1 corresponding to residues 184 to 205 of Mdh Bm MGA3 consists of the conserved sequence SEQ ID NO 13:AGLTIATGMDALSHAIEAYVAK

[0134] Conserved region 2 corresponding to residues 248 to 284 Mdh Bm MGA3 consists of the conserved sequence SEQ ID NO 14:MAGVAFNNGGLGLVHSISHQVGGVYKLQHGICNSVNM

[0135] It is further postulated that recombinant Mdh enzymes of the overoxidizing class have reduced or no ability to oxidize formaldehyde to formate, if the corresponding regions of a recombinant overoxidizing class enzymes is replaced by either one or by both of the conserved regions 1 and / or 2 of the Mdh / Mdhl class enzyme.ETHZ-37-PCT

[0136] In short, the absence or presence of at least one of the two conserved regions 1 (SEQ ID NO 13) and 2 (SEQ ID NO 14) in the Mdh enzyme is thought to be important for the turn-over rate of formaldehyde as a substrate.24 conserved residues provide a switch between oveand non-i

[0137] In addition to the conserved regions 1 and 2, one or more of selected conserved aa residues, which are identified in bold in Figure 15, were speculated to be relevant for the ability of the Mdh enzymes to oxidize formaldehyde.

[0138] These residues correspond to the following positions in the Mdh Bm MGA3:V12, 113, 128, F40, Q68, D70, A72, Q75, L91, 194, Q120, N123, V125, V132, V133, T136, L148, V150, P161, V162, 1163, A184, 1188, S196, A204, K205, V210, M248, V251, G256, L260, S263, S265, V271, K273, Q275, 1278, S281, N283, M284, L326, M342, S364 V368, V371.

[0139] Of these residues A184, 1188, S196, A204, K205 and M248, V251, G256, L260, S263, S265, V271, K273, Q275, 1278, S281, N283, M284 are contained in the conserved regions 1 and 2.

[0140] It was speculated that it would thus be possible, to introduce overoxidizing properties in the Mdh Bm MGA3 enzyme, or another Mdh / Mdhl class enzyme, by replacing one or more of the conserved residues with the corresponding residues in the overoxidizing class enzymes:V12L, I13F, I28L, F40G, Q68E, D70N, A72T, Q75N, L91I, I94L, Q120E, N123D, V125S, V132L, V133I, T136N, L148F, V150I, P161A, V162I, 1163V, A184P, I188A, S196T, A204S, K205T, V210I, M248L, V251M, G256A, L260Y, S263A, S265A, V271F, K273N, Q275P, 1278V, S281A, N283L, M284L, L326I, M342L, S364T V368K, V371L

[0141] In analogy, it was speculated that it would also be possible to replace these corresponding conserved residues in an overoxidizing class enzyme with theETHZ-37-PCTabove listed residues of Mdh Bm MGA3, to reduce or abolish overoxidizing activity of the overoxidizing class enzyme.

[0142] To establish which of the identified conserved amino acids conferred overoxidizing ability to the Mdh enzymes, an extended alignment with additional Mdh sequences was performed. Based on this alignment a series of mutant enzymes was generated and tested for their ability to oxidize methanol and formaldehyde in vitro. The tests led to the identification of a set of 24 amino acids, which are conserved in both, class Mdh / Mdhl enzymes and class Mdh2 / Mdh3 enzymes, but which differ between these classes. These conserved 24 amino acid residues are indicated with black triangles in the sequence alignment shown in Figure 15.

[0143] It could be established that mutation of these 24 conserved amino acids only in the non-overoxidizing Mdh Bm MGA3 enzyme to the respective conserved amino acid residues of the overoxidizing Mdh2 CT4-1 Cn enzyme resulted in a mutant enzyme Mdh Bm MGA3 mutant (SEQ ID NO 21) with overoxidizing abilities, as shown in Figures 14A Compared to the Mdh Bm MGA3 non-overoxidizing enzyme (identified as "wt" in Figure 14A) the Mdh Bm MGA3 mutant had gained the ability to oxidize formaldehyde to formate. However, oxidization of methanol by Mdh Bm MGA3 mutant (Figure 14B) was significantly slower compared to the wild-type non-overoxidizing enzyme Mdh Bm MGA3 (Figures 14C).

[0144] These results indicate that mutation of the identified 24 amino acids in a non-overoxidizing Mdh enzymes to the conserved residues of the overoxidizing Mdh enzymes are sufficient to introduce the ability to oxidize formaldehyde to formate. Conversely, the mutation of the identified 24 amino acids in an overoxidizing Mdh enzyme to the conserved residues of the non-overoxidizing Mdh enzymes is thought to be sufficient to drastically reduce, i.e. reduce by more than 70% or more than 90%, or entirely abolish the enzyme's ability of oxidizing formaldehyde to formate.

[0145] The identified 24 amino acid residues thus together act as a switch between overoxidizing and non-overoxidizing properties of Mdh enzymes.

[0146] As part of this study, it was shown for the first time that the overoxidation of methanol to formate is a common characteristic among NAD-ETHZ-37-PCTdependent methanol dehydrogenases. Even though this ability is common, it is not universal and it was further found that Mdh enzymes belonging to the Mdh / Mdhl class do not share this ability to catalyze the oxidation of formaldehyde to formate. Instead, these enzymes only catalyze the oxidation of methanol to formaldehyde.

[0147] The difference between these two classes of Mdh enzymes is highly relevant, as it permits to generate recombinant methylotrophic strains which metabolise methanol through the RuMP cycle and do not accumulate formate as a result of overoxidation of the methanol substrate. The findings therefore allow for a more efficient industrial production of value-added metabolites without the production of significant amounts of formate as by-product.

[0148] Relevant regions in the Mdh enzymes were identified which impact the enzymes oxidation ability.

[0149] In addition, a 24 amino acid switch between non-overoxidizing and overoxidizing activity was identified, thereby enabling the generation of tailored non-overoxidizing Mdh enzymes suitable for the production of desired carbon products from Cl substrates with reduced or no formation of formate as a side product.

[0150] The capability of the overoxidizing class enzymes to oxidize formaldehyde to formate suggests that their main role is not the oxidation of methanol but the detoxification of formaldehyde. Canonically, B. methanolicus detoxifies formaldehyde via the oxidative pentose phosphate pathway, which requires the regeneration of the one-carbon acceptor ribulose 5-phosphate (Ru5P). However, when Ru5P regeneration is ineffective, formaldehyde detoxification cannot take place. In this case, the overoxidizing class enzymes might serve as a backup system for the detoxification of formaldehyde, while at the same time supporting the oxidation of methanol to formaldehyde as soon as Ru5P pools have been restored. It might thus be particularly important during transition phases of changing environmental conditions with sudden up- or down shifts of methanol. Whether such a system has only evolved in B. methanolicus remains open, but so far, this is the only species in which both overoxidizing and non-overoxidizing Mdh enzymes have been found.ETHZ-37-PCT

[0151] The finding that Mdh / Mdhl type enzymes catalyze oxidation of methanol to formaldehyde and that overoxidizing enzymes catalyze oxidation methanol to formate, is not only important for our understanding of natural methylotrophs but also to inform the engineering of synthetically methylotrophic microbial strains, for example E. coli strains, for product formation.

[0152] Production yields close to the theoretical maximum will be important to realize economically profitable bioprocesses from methanol by methylotrophic organisms. The production of formate by synthetically methylotrophic E. coli has a negative impact on the process yield. To enable its assimilation, an additional heterologous pathway such as the reductive glycine pathway could be implemented. However, its coordination with the already introduced RuMP cycle would be challenging. Notably, the overoxidation of methanol to formate is not a problem for a strain that exclusively utilizes the reductive glycine pathway.

[0153] Another potential solution to utilize the formate would be the expression of a formate dehydrogenase. While the carbon would still be lost, the oxidation of formate to CO2 would provide additional reducing equivalents for the production of chemicals. However, this would only be beneficial for highly reduced products as methanol as a substrate already provides an excess of reducing equivalents for most industrially relevant products.

[0154] As an ideal solution, the production of formate is therefore prevented to avoid any loss of carbon and reducing equivalents.

[0155] This aim is attained by the present invention, based on the use of nonoveroxidizing Mdh enzymes in recombinant methylotrophic strains, leading to a significant reduction of formate formation in bioproduction cultures. The generation of a synthetically methylotrophic E. coli strain which does not produce formate as side product provides an important step towards economical bioprocesses to produce green chemicals from methanol and the establishment of a circular carbon economy.MethodsPlasmidsETHZ-37-PCT

[0156] NAD-dependent Mdh genes were expressed from plasmids based on the pSEVA434 backbone, specifically Mdh_Bm_MGA3 from pSEVA434_mdh_Bm_MGA3 (SEQ ID NO 15) in experiments shown in Figures 3A, and 8A and Mdh2 CT4-1 Cn from pSEVA434_mdh2_CT4-1_Cn (SEQ ID NO 23) in experiments shown in Figures 3A, 8B, 12A and 13.

[0157] RuMP cycle genes were expressed from a plasmid based on the pSEVA131 backbone from the synthetic methylotrophic E. coli strain MEcoli_ref_2 (pSEVA131_hps_phi_Mf, SEQ ID NO 16.

[0158] For Figure 1A and Figure 8B, plasmids were isolated from the evolving population in between MEcoli_ref_l, an earlier methylotrophic isolate, and MEcoli_ref_2 (WQ2024018304A1). The coding sequence for methanol dehydrogenase 2 variant CT4-1 from Cupriavidus necator (mdh2 CT4-1 Cn, SEQ ID NO 10) was synthesized by Eurofins.

[0159] For full methylotrophic growth using the non-overoxidizing mdh Bm MGA3 gene and RuMP cycle genes hps and phi Mf, genes were expressed from pSEVA131_mdh_Bm_MGA3_hps_Mf_phi_Mf, SEQ ID NO 22 in experiments shown in Figures 11, and 12B.

[0160] Methanol dehydrogenase from Bacillus methanolicus MGA3 (mdh Bm MGA3, SEQ ID NO 1) encoding gene was amplified from pET21a plasmids.

[0161] For expression and purification of mdh2 CT4-1 Cn, mdh Bm MGA3 and mdh Bm MGA3 mutant, the genes were amplified by PCR using primers with overhangs. The PCR products were cloned into a modified pET-16b expression vector where the Hisw-tag and linker region had been omitted, using Gibson Assembly.

[0162] pET16b plasmid constructs encoding mdh2 CT4-1 Cn and mdh Bm MGA3 were transformed into E. coli DH5a, and correct plasmid assembly was confirmed by Sanger sequencing. The nucleotide sequence encoding Mdh Bm MGA3 mutant was synthesized and cloned into the pET16b vector by Twist Bioscience. For heterologous expression, the obtained plasmids were transformed into E. coli BL21-Gold (DE3) cells.ETHZ-37-PCTpET16b vectors were used for expression of enzymes which were then purified for in vitro experiments.

[0163] pET21a expression plasmid containing the activator act Bm MGA3 (Uniprot No. I3EA59, Arfman et al (J. Biol. Chem. (1991)), DOI: 10.1016 / S0021-9258(19)67886-5) have been described earlier and were received from SINTEF, Norway. It was transformed into E. coli BL21-Gold (DE3) cells for expression.

[0164] Plasmids used to screen different NAD-dependent methanol dehydrogenases for overoxidation were cloned using isothermal assembly utilizing the commercially available HIFI DNA Assembly mastermix.Strains

[0165] The synthetic methylotrophic E. coli strain MEcoli_ref_2 is able to grow on methanol as its sole carbon and energy source and was described in a previous study (W02024018304A1).

[0166] The fully methylotrophic strain M Fu I l_Eco li used in this study was generated as follows: E. coli strain BW25113 AfrmAAtpiA containing pSEVA424 mdh2 CT4-1 C. necator and pSEVA131 hps and phi M. flagellatus was evolved by chemostat and serial dilution evolution towards growth on methanol as described in previous studies (Keller et al, Nat. Comm. (2022), DOI: 10.1038 / s41467-022-32744-9). The resulting methylotrophic strain was then cured by its plasmids by serially streaking it out on LB agar plates. Successful curing was confirmed by PCR and test for antibiotic resistance showing both plasmids had been lost. The cured strain was transformed with pSEVA131 mdh B. methanolicus MGA3, hps M. flagellatus and phi M. flagellatus (pSEVA131_mdh_Bm_MGA3_hps_Mf_phi_Mf (SEQ ID NO 22)) and plated onto LB agar plates containing 20 mM pyruvate and ca rbenici Ilin. 12 colonies were inoculated in LB supplemented with 20 mM pyruvate and ca rbenicil lin until growth was observed. The cultures were diluted into M9 medium supplemented with 500 mM methanol and 20 mM pyruvate. When growth was observed, cultures were diluted again into the same conditions. Subsequently, cultures were diluted into M9 medium supplemented with 500 mM methanol and 0.1 g / L yeast extract for three more cycles until growth in the absence of yeast extract supplementation was observed. The resulting culture wasETHZ-37-PCTfurther evolved by serial passaging in M9 medium supplemented with 500 mM methanol towards faster growth on methanol as previously described (Reiter, M. A. et al.; Nat. Catal. 7, 560-573 (2024); D0ll0.1038 / s41929-024-01137-0). When the culture reached an approximate doubling time of three hours, it was streaked out onto a M9 medium agar plate supplemented with 500 mM methanol. Single colonies were analyzed for their growth rate on methanol and the fastest growing isolate was labelled MFull_Ecoli and used for further experiments.

[0167] For growth on methanol the M Ful l_Ecoli strain was inoculated in 30 mL M9 medium supplemented with 500 mM methanol. When growth was observed, cultures were diluted to an initial ODeoo of 0.05 in the same medium into nine replicates. Growth was monitored by regularly sampling the cultures and measuring its ODeoo value. Cultures were incubated at 37 °C under stirring (220 r.p.m., 25 mm throw).

[0168] The methanol-dependent E. coli strain AfrmAAtpiA expressing the RuMP cycle genes mdh, hps and phi, also referred to as MDep_Ecoli, having the CCOS accession number CCOS 2133, was generated using the previously described ancestral strain for the adaptive laboratory evolution (Keller et al., Nat. Comm. (2020), DOI: 10.1038 / s41467-020-19235-5) which generated E. coli strain MEcoli_ref_2 (Keller et al (Nat. Comm. (2022), DOI: 10.1038 / s41467-022-32744-9)). MDep_Ecoli heterologously expresses Mdh Bm MGA3.

[0169] The E. coli strain Screen_Ecoli, having the CCOS accession number CCOS 2134, which lacks the canonical formaldehyde detoxification pathway (AfrmRAB), was used to screen different methanol dehydrogenases for overoxidation of methanol to formate in vivo.Formate production by MEcoli_ref_2 during growth on methanol in a bioreactor

[0170] Supernatant samples were derived from bioreactor runs of MEcoli_ref_2 and analyzed by LC-MS.L-lactic acid, and itaconic acid production and formate side-production by MEcoli_ref_2 and MFull_Ecoli from methanol in shake flasksETHZ-37-PCT

[0171] Production of L-lactic acid and itaconic acid was performed as previously described (Reiter, M. A. et al.; Nat. Catal. 7, 560-573 (2024); DOI10.1038 / s41929-024-01137-0). The cryogenic glycerol stocks of MEcoli_ref_2 transformed with pljac (lactic acid production), MEcoli_ref_2 transformed with pljta (itaconic acid production), and M Fu ll_Ecoli transformed with pljta (itaconic acid production) were inoculated in 20 ml volume of M9 medium supplemented with 500 mM methanol (MEcoli_ref_2) and 750 mM methanol (M Ful l_Ecoli), 0.1 g L1yeast extract and 4.25 pg / mL chloramphenicol in baffled 100 ml shake flasks. The cultures were incubated at 37 °C, 220 revolutions per minute (r.p.m.)., 25 mm throw. For the MEcoli_ref_2 cultures, in the exponential growth phase, eight replicate 20 ml cultures in M9 medium containing 500 mM methanol were inoculated to an initial ODeoo of 0.05. At ODeoo ~ 1.2 (pl_lac) and ODeoo ~ 1.0 (pljta), production was induced by transferring the cells to fresh medium containing 500 nM anhydrotetracycline (ate). For the MFull_Ecoli cultures, in the exponential growth phase, three replicate 30 ml cultures in M9 medium containing 750 mM methanol were inoculated to an initial ODeooof 0.03. At ODeoo ~ 1.25 (pljta), production was induced by transferring the cells to fresh medium containing 500 nM anhydrotetracycline (ate). For the transfer, the cultures were centrifuged for 7 min at 3,220 g, the supernatant discarded, and the cells resuspended in fresh medium.Cultures were incubated in the dark at 37 °C with the following shaking conditions for MEcoli_ref_2: 180 r.p.m., 50 mm throw; and for MFull_Ecoli: 220 r.p.m., 25 mm throw. For supernatant sampling, 500 pL of culture were centrifuged for 1 min at 11'000 g, 450 pL of supernatant transferred to a fresh tube and stored at -20 °C until further analysis. Formate and itaconic acid were quantified by LCMS, L-lactic acid by a commercially available enzymatic kit.Quantification of L-lactic acid

[0172] L-lactic acid in the culture supernatant was quantified by a commercially available enzyme kit (L-Lactic Acid (L-Lactate) Assay Kit, K-LATE, Megazyme) according to the manufacturer protocol.Quantification of formate and itaconic acid by LC-MS

[0173] Organic acids in the culture supernatant were derivatized together with an internal standard. 200 pM sodium propionate was used as internal standard for theETHZ-37-PCTsimultaneous quantification of formate and itaconic acid, and for the determination of12C / 13C formate ratio in the isotopic tracer experiment displayed in Figure 1C. For the analysis of the MFull_Ecoli supernatant samples and when only formate was quantified, 1 mM of isotopically labelled13C formate was used as internal standard.

[0174] Samples were diluted 20-fold in 50% (v / v) acetonitrile and 34 mM 3-nitrophenylhydrazine and 21 mM N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide were added. Samples were incubated at 40 °C with continuous shaking for 1 h to facilitate the derivatization reaction. The reaction was quenched by the addition of 0.02% (v / v) trifluoroacetic acid and diluted 10-fold in 50% (v / v) acetonitrile.Derivatized samples were analyzed using UPLC with a C18 column with isobutyl side chains and tetramethylsilane end capping (Kinetex Core-Shell Technology XB-C18: 2.1 x 50 mm, 1.7 pm particle size, 100 A pore size, Phenomenex) coupled to a hybrid quadrupole-orbitrap mass spectrometer. Solvents were 0.1% (v / v) formic acid in ultrapure water (solvent A) and in acetonitrile (solvent B).

[0175] For metabolite separation, the following gradient was used at a constant flow rate of 500 pL min-1: 98% solvent A linearly decreased to 5% in 3 min, then held at 5% A for 2 min, then linearly increased to 98% in 0.3 min and held at 98% for a final 2 min. Fourier-transform MS was performed in negative mode with a spray voltage of -3.0 kV, a capillary temperature of 275 °C, an S-lens radiofrequency level of 50, an auxiliary gas flow rate of 20 a.u. and an auxiliary gas heater temperature of 350 °C. Mass spectra were recorded as centroids at a resolution of 35,000 at an m / z of 200 with a mass range of 150-1,000 m / z and a scan rate of ~4 Hz in full scan mode. 2 pL of sample was injected. Organic acids were quantified using pure formic acid or itaconic acid as external standards diluted in M9 medium derivatized with internal standard as described above. Metabolite peaks were extracted via a targeted approach using the external standard to define retention time-m / z peak windows applying an m / z tolerance of 10 ppm. Integration was performed using trapezoid integration. The13C formate internal standard was corrected for the natural abundance of labelled formate in the sample and of labelled derivatization reagent.Adaptation of methanol-dependent strains to growth without yeast extractETHZ-37-PCT

[0176] The methanol-dependent AfrmAAtpiA and AfrmRABAtpiA strains require yeast extract as growth accelerator, which can be omitted after a couple of serial passages. For the adaptation of a strain to growth without yeast extract, cells were adapted in different conditions. Concentrations applied were methanol (500 mM for strains expressing Mdh2 CT4-1 Cn, 20 mM pyruvate, 0.1 g L1yeast extract in 20 mL M9 medium also containing, if indicated, Carb or Amp, Sm, IPTG. 100 mL baffled shake flasks were used as vessels. The first passage was inoculated from a cryogenic glycerol stock. Cultures were incubated at 37 °C using a Multitron shaker at 220 r.p.m., 25 mm throw.

[0177] Once cells reached stationary phase, cultures were diluted. Passaging was repeated until growth without yeast extract was observed and the adapted culture was stored as cryogenic glycerol stock (25% glycerol) at -80 °C until further analysis.Formate production during methanol-dependent growth

[0178] The cryogenic glycerol stock of the adapted methanol-dependent AfrmAAtpiA strain expressing the RuMP cycle genes mdh2 CT4-1 H165N Cn, hps Mf, and phi Mf (plasmids were isolated from an evolutionary stage between MEcoli_ref_l and MEcoli_ref_2) were streaked out on a M9 minimal medium agar plate containing 500 mM methanol, 20 mM pyruvate, Sm, Amp and incubated at 37 °C until colonies were formed. Four single colonies were inoculated in 20 mL M9 medium containing 500 mM methanol, 20 mM pyruvate, 0.1 g L1yeast extract, Amp, Sm, IPTG in 100 mL baffled shake flasks and incubated at 37°C using a Multitron shaker at 220 r.p.m., 25 mm throw. Once cells reached late exponential / stationary phase, they were diluted by pipetting the required volume of culture into fresh medium with the same composition but without yeast extract. Once cells reached exponential phase, they were diluted again for the main culture. For supernatant sampling, 500 pL of culture were centrifuged for 1 min at 11'000 g, 450 pL of supernatant transferred to a fresh tube and stored at -20 °C until analysis by LC-MS.

[0179] For the adapted methanol-dependent strain harboring the same plasmids but containing a deletion of the entire formaldehyde detoxification pathwayETHZ-37-PCToperon (AfrmRABAtpiA), the same procedure was followed but there was only one preculture and it was directly inoculated from a cryogenic glycerol stock.

[0180] For the adapted methanol-dependent AfrmAAtpiA strain expressing mdh Bm MGA3, hps Mf, and phi Mf, the same procedure was followed but the preculture originated from the seventh passage of lineage 1 of its adaptation to growth without yeast extract and were passaged another 5 times until formate in the supernatant was quantified.Isotopic labelling experiment to determine origin of formate during methanoldependent growth

[0181] The preculture handling and conditions were the same as described for the adapted methanol-dependent AfrmAAtpiA strain expressing the RuMP cycle genes mdh2 CT4-1 Cn H165N, hps Mf, and phi Mf in the previous paragraph with the following exceptions: 500 mM13C instead of12C methanol was used for the 2ndpreculture and the main culture; the culture volume was 10 mL; for the passaging from the 1stto the 2ndpreculture, cells were transferred by centrifugation of the required culture volume, discarding the supernatant, and solution of the cell pellet in the fresh medium. Supernatant samples were also analyzed by LC-MS.Heterologous expression of enzymes

[0182] E. coli BL21-Gold (DE3) cells containing the expression vector were grown in 200 mL LB medium supplemented with Carb in 2 L baffled shake flasks at 37 °C using a Multitron shaker at 220 r.p.m., 25mm throw. At an OD600 of about 0.7 (midexponential phase) the expression was induced with 0.3 mM IPTG and the culture was incubated overnight (about 16 h) at 16 °C at 180 r.p.m. The cells were harvested by centrifugation (11'000 g, 10 min, 4 °C) and either stored at -20°C or directly used for purification.Purification of Methanol dehydrogenases

[0183] Cell pellets were resuspended using 25 mL of buffer A (20 mM Tris, 20 mM NaCI, 2 mM DTT, pH 7.4) supplemented with Roche complete EDTA-free proteaseETHZ-37-PCTinhibitor cocktail. Cell lysis was performed by sonication (6 mm sonication probe, amplitude 30, process time 4 min, impulse time 5 s followed by 25 s cooling, Q700 sonicator) and cell debris was removed by centrifugation (18'000 x g, 40 min, 4°C).

[0184] As first chromatographic step to obtain untagged Mdh2 CT4-1 Cn, Mdh Bm MGA3, Chimera 1 and Mdh Bm MGA3 mutant the lysate was purified using a 1 or 5 mL HiTrap Q HP anion exchange column by applying a linear gradient of buffer A to buffer B (20 mM Tris, 1 M NaCI, 2 mM DTT, pH 7.4). The gradient was run at 1 or 5 mL / min from 0% B to 60% B in 30 min. The collected fractions were analyzed by SDS-PAGE, and fractions containing Methanol dehydrogenase were pooled and concentrated using 30 or 50 kDa centrifugal filter units.

[0185] As a next step, the sample was purified by size exclusion chromatography using Superdex 200 Increase 10 / 300 GL column run with buffer C (50 mM phosphate buffer, 150 mM NaCI, 5 mM MgSC, pH 7.4). The Methanol dehydrogenase-containing fractions were collected and concentrated. Protein concentration was determined by absorption measurement at 280 nm using a NanoDrop spectrophotometer and the calculated extinction coefficient of 21430 M1cm1(Mdh2 CT4-1 Cn), 11920 M1cm1(Mdh Bm MGA3, Mdh Bm MGA3 mutant) or 15930 M1cm1(Chimera 1) respectively. The enzymes were stored at 4 °C.In vitro enzyme assays

[0186] Activity assays were performed in cuvettes using a Cary 50 Bio UV-Visible spectrophotometer. Methanol dehydrogenase activity was assayed in reaction buffer (buffer C) supplemented with 12.3 pM Mdh2 CT4-1 Cn or 3.1 or 10 or 12.5 pM Mdh Bm MGA3 or 126.5 pM Chimera 1 or 10 pM Mdh Bm MGA3 mutant and 5 mM NAD+at 37 °C or 50 °C. For the in vitro measurements involving Act, 1 or 2.3 pM activator protein (Act) was added. Assays were started by adding preheated (10 min) methanol or formaldehyde reaction buffer solution (10 pL) to preheated reaction buffer containing Mdh and NAD+, followed by mixing by pipetting up and down. The reaction was monitored by measuring the increase in NADH at 340 nm and the NADH calculated from its extinction coefficient (E340 = 6220 M1cm-1).ETHZ-37-PCT

[0187] To measure activity until equilibrium was reached, the assay was performed using a microplate reader and 25 pM enzyme. The equilibrium concentrations of formaldehyde, formate, and NADH were determined by the following methodologies: Formaldehyde was quantified by Nash assay. Formate was quantified by NMR. NADH was quantified by the absorbance of the reaction solution at 340 nm, using a standard curve obtained with a commercially available NADH standard.

[0188] In the initial range of in vitro reactions, the concentrations of formaldehyde or formate were often too small for reliable direct quantification. For this reason, NADH conversion was used as a readout for the initial activity as it correlates directly with the formation of either formaldehyde (from methanol) or formate (from formaldehyde) in the in vitro assay.Formate production of the AfrmRAB strain harboring plasmids encoding different NAD-dependent methanol dehydrogenases

[0189] From cryogenic glycerol stocks, the adapted AfrmRAB strains harboring an empty pSEVA424 plasmid backbone isolated from MEcoli_ref_2 or expressing different NAD-dependent Mdh enzymes were inoculated into 4 mL LB cultures in 12 mL plastic culture tubes and grown to stationary phase at 37 °C using a Multitron shaker at 220 r.p.m, 25 mm throw. Triplicate cultures were then inoculated in 20 mL M9 medium containing 20 mM pyruvate and 500 mM methanol to a starting OD600 of 0.05. 100 mL baffled shake flasks were used as vessels. Culture supernatants were sampled at 5, 22, 46, and 69 hours after inoculation. Samples for the quantification of formate by HPLC were generated by centrifugation of 500 pL of cell culture at 11'000 g, 4 °C for 3 minutes. Next, 400 pL of the supernatant was carefully aspirated and subsequently stored in screw-cap tubes at -20 °C until analysis by HPLC.Formate guantification by HPLC

[0190] Formate in the supernatant of the cultures for the methanol dehydrogenase screen for overoxidation of methanol was quantified via UPLC equipped with a Rezex ROA UPLC column (Rezex ROA-Organic Acid H+ (8%):300 x 7.8 mm; Phenomenex) coupled to a variable wavelength detector VWD-3400 byETHZ-37-PCTmonitoring the absorbance at 210 nm. 2.5 mM sulfuric acid in ultrapure water was used as solvent at an isocratic gradient and a flow rate of 600 pL min-1. 20 pL of sample was injected. Peaks were identified and the peak areas were quantified based on an external standard curve of pure formic acid utilizing a standard dilution series in ultrapure water. Prior to injection, samples were diluted 1:1 (v / v) in ultrapure water and standards 1:1 (v / v) in M9 medium to exclude matrix effects.Phylogenetic analysis

[0191] Enzyme sequences aligned had the following Uniprot identifiers: Mdh Bm MGA3, Q6TV41; Mdh2 Bm MGA3, I3E2P9; Mdh3 Bm MGA3, I3E949; Mdh Bm PB1, I3DTP7; Mdhl Bm PB1, I3DX19; Mdh2 Bm PB1, I3DVX6; Mdh2 Cn WT F8GNE5. The Mdh2 CT4-1 variant used in this study is A26V, A31V, A169V compared to the wildtype (WT) enzyme; Mdh Lx, A0A0K9F7R7; Mdh Gs, P42327.

[0192] The sequence alignment was performed using MUSCLE in the EMBL-EBI Job Dispatcher sequence analysis tools framework web tool74 and the phylogenetic tree was visualized by ETE375.Purification of Activator protein (Act)

[0193] Hise-tagged Act Bm MGA3 was purified by resuspending cell pellets in 20 mL buffer A (50 mM phosphate, 300 mM NaCI, 20 mM imidazole, 2 mM DTT, pH 8) supplemented with Roche complete EDTA-free protease inhibitor. Cell lysis and clearance of cell debris was performed as described above.

[0194] Act was isolated from the lysate by affinity chromatography using a 1 mL HisTrap HP column and applying a linear gradient of buffer A to buffer B (50 mM phosphate buffer, 300 mM NaCI, 500 mM imidazole, 2 mM DTT, pH 8). The gradient was run at 1 mL / min from 0% B to 100% B in 25 min. Fractions containing Act were pooled and analyzed by SDS-PAGE. Buffer was exchanged to reaction buffer (50 mM phosphate buffer, 5 mM MgSO4, pH 7.4) by repeated concentration using 10 kDa centrifugal filter units and refills with reaction buffer until a dilution factor of at least 30'000 was achieved. Protein concentration was determined by absorptionETHZ-37-PCTmeasurement at 280 nm using a NanoDrop spectrophotometer and the calculated extinction coefficient of 14'440 M1cm-1. The enzyme was stored at 4 °C.Calculation of equilibrium concentrations

[0195] For a methanol overoxidizing Mdh, the oxidation of methanol to formaldehyde and of formaldehyde to formate was considered, while for a nonoveroxidizing Mdh only the methanol to formaldehyde oxidation. Estimated ArG'° were derived from the eQuilibrator web tool for the conditions present in the in vitro assays (pH = 7.4, pMg = 2.3, ionic strength = 0.15 M) and are 32 kJ / mol and -49.6 kJ / mol. The initial concentration of methanol is 500 mM and of NAD+5 mM.Equilibrium concentrations of methanol [MeOH], formaldehyde [FALDH], formate [FA], [NAD+] and [NADH] were derived from the following non-linear equation system for overoxidizing Mdh's:5 = [NAD+] + [NADH] (5)

[0196] For non-overoxidizing Mdh's, the following non-linear equation system was solved:[FALDH] * [NADH]fci[MeOH] * [NAD+] (1)500 = [MeOH] + [FALDH] (6)[NADH] = [FALDH] (7)5 = [NAD+] + [NADH] (5)Formaldehyde quantification by Nash assay

[0197] To quantify formaldehyde in samples from in vitro assays, 20 pL sample (collected at equilibrium, after 180 min) was taken from the assay mixture and mixedETHZ-37-PCTwith 20 pL Nash reagent (2 M ammonium acetate, 0.05 M acetic acid, 0.02 M acetylacetone). Following an incubation of 40 min at 37 °C, absorbance at 412 nm was measured using a microplate reader. Formaldehyde concentrations were calculated with a standard curve obtained by measuring the absorbance at 412 nm of known formaldehyde concentrations.Methanol, formaldehyde and formate quantification by NMR

[0198] 90 pL of reaction mixture were mixed with 20 pL D2O containing 10 mMDSS-D6 (98 %). 80 pL of 20 mM sodium acetate buffer and 10 pL of 1 M acetic acid were added to acidify the sample. This mixture resulted in a final DSS proton concentration of 1000 pM. The prepared solutions were transferred to 3 mm NMR tubes, suitable for use with the SampleJet system.

[0199] NMR data were acquired at 298.0 K at a 600 MHz Bruker AVIII Avance HD NMR spectrometer equipped with a CP-QCI-1H / 19F-13C / 15N-2H 05 Z cryoprobe. The system included a SampleJet sample handling robot for automation, with the samples stored at 278 K between the experiments.ID1H Experiments

[0200] The experiments were acquired with 65536 complex data points and 64 transients. The pre-scan relaxation delay was set to 4.0 s. The solvent signal was suppressed by applying pre-saturation during the pre-scan delay and by applying a short (10 ms) NOE mixing period followed by a z-gradient before the final TT / 2 pulse. Data were zero-filled to 131072 points, and a squared cosine window function was applied. The resulting spectra were baseline-corrected before peak integration. Peak integrals of metabolites were normalized to the integral of DSS at 0 ppm for concentration determination.ID13C Experiments

[0201] The experiments were acquired with 53056 complex data points and 6144 transients. The pre-scan relaxation delay was set to 2.0 s. The carrier frequency was set to 97 ppm and the spectral width to 251 ppm. The1H channel was saturatedETHZ-37-PCTduring the pre-scan delay to enhance the13C signal due to heteronuclear nuclear Overhauser enhancement. For 1H broadband decoupling during the acquisition and1H saturation during the pre-scan delay, the WALTZ-6582,83 scheme was applied. Data were zero-filled to 131072 points, and a squared cosine window function was applied. The resulting spectra were baseline-corrected before peak integration.

[0202] Data acquisition and processing were performed using TopSpin 3.6. Formate was quantified using pure formic acid as external standard diluted in M9 medium.

[0203] The nucleotide sequences encoding the Chimera enzymes 1 and 2 were synthesized by Twist Bioscience and cloned into a pET16 expression vector using Gibson assembly.Whole cell enzyme assay to test overoxidation of methanol to formatepET16 expression vector were transformed into BL21(DE3) Gold cells with an interrupted formaldehyde detoxification pathway AfrmA and stocked as cryogenic glycerol stock. Cryogenic glycerol stocks were streaked out onto LB plates containing ca rbenici Ilin and a single colony inoculated into 20 mL LB containing carbenicillin in a 100 mL baffled shakeflask. Cells were incubated at 37 °C until the cultures reached an OD600 between 0.6 - 0.8 using a Multitron shaker at 220 r.p.m., 25 mm throw. When the target density was reached, cultures were put at 16 °C for 30 min using a Multitron shaker at 220 r.p.m., 25 mm throw and subsequently, protein expression was induced by the addition of 0.3 mM IPTG. Cultures were incubated at 16 °C overnight for protein expression. The next day was protein expression confirmed by SDS PAGE and three times 1.2 mL of culture were transferred into a 24-well deep well plate per strain. 800 mM 13C methanol was added to each well and the cells incubated at 37 °C. After 10 h, the supernatant was sampled by centrifugation of 250 pL culture for 1 min at 11'000 g and 220 pL of supernatant were transferred to a fresh tube. Samples were stored at 20 °C until methanol, formaldehyde, and formate quantification by NMR.ETHZ-37-PCT

Claims

Claims1. A recombinant non-naturally occurring methanol-dependent or fully methylotrophic microorganism,which heterologously expresses or over-expresses a polypeptide having methanol dehydrogenase (Mdh) activity,wherein the initial maximum velocity of the oxidization of formaldehyde to formate reaction catalysed by said polypeptide having Mdh activity measured as [OMNADH second1pMenzyme-1], is less than 1, or less than 0.1, said VmaxCHzO being determined by monitoring NADH production at 340 nm in an in vitro assay at pH 7.4, at a temperature selected from 37 °C to 50 °C, said assay temperature being selected according to the optimal growth temperature of the microorganism from which the enzyme is derived, using formaldehyde at concentrations of 50 mM to 500mM.

2. The recombinant microorganism of claim 1, which further expresses or overexpresses a polypeptide having 3-hexulose-6-phosphate synthase (Hps) activity, and a polypeptide having a 6-phospho 3-hexuloisomerase (Phi) activity, and / or which does not comprise, or which comprises deletions or reductions of expression of, or eliminations or reductions of activity of a polypeptide having triose-phosphate-isomerase activity and of a polypeptide having glutathione-dependent formaldehyde dehydrogenase activity.

3. The recombinant microorganism of claim 1 or 2, said polypeptide having methanol dehydrogenase (Mdh) activity comprising the following amino acid residues:- an aspartic acid (D) residue corresponding to the D70 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an alanine (A) residue corresponding to the A72 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glutamine (Q) residue corresponding to the Q75 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),ETHZ-37-PCT- a isoleucine (I) residue corresponding to the 194 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glutamine (Q) residue corresponding to the Q120 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a threonine (T) residue corresponding to the T136 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a leucine (L) residue corresponding to the L148 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a valine (V) residue corresponding to the V150 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a proline (P) residue corresponding to the P161 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an isoleucine (I) residue corresponding to the 1163 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an isoleucine (I) residue corresponding to the 1188 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S196 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an alanine (A) residue corresponding to the A204 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a lysine (K) residue corresponding to the K205 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a valine (V) residue corresponding to the V251 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),ETHZ-37-PCT- a glycine (G) residue corresponding to the G256 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S263 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S265 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glutamine (Q) residue corresponding to the Q275 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a isoleucine (I) residue corresponding to the 1278 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S281 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a methionine (M) residue corresponding to the M284 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a leucine (L) residue corresponding to the L326 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), and- a methionine (M) residue corresponding to the M342 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1).

4. The recombinant microorganism of any of claims 1 to 3, said polypeptide having a Mdh activity has at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 1.

5. The recombinant microorganism of any of claims 1 to 4, wherein the polypeptide having a Mdh activity is selected from a group consisting of SEQ ID NO 1, SEQ ID NO 2, SEQ ID NO 3, SEQ ID NO 4, SEQ ID NO 5, SEQ ID NO 6.ETHZ-37-PCT6. The recombinant microorganism of any of claims 3 to 5, said polypeptide having a Mdh activity being a variant of a polypeptide having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 7.

7. The recombinant microorganism of any of claims 1 to 6, wherein the polypeptide having a Mdh activity comprises a sequence having at least 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 13 and / or comprising a sequence having at least 60%, 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 14, wherein said sequences, if both present in the polypeptide are spaced at least 40 residues apart, for example 40 to 50 or 40 to 45 residues apart.

8. The recombinant microorganism of any of claims 1 to 7, expressing or overexpressing a polypeptide having a Nudix hydrolase Act (SEQ ID NO 12) activity.

9. The recombinant microorganism of any of claims 1 to 8, expressing or over expressing all enzymes required for a complete ribulose monophosphate (RuMP) cycle, consisting of a polypeptide having methanol dehydrogenase activity, such as Mdh, a polypeptide having 3-hexulose 6-phosphate synthase, such as Hps, a polypeptide having 6-phospho 3-hexuloisomerase activity, such as Phi, a polypeptide having glucose-6-phosphate isomerase activity, such as Pgi, a polypeptide having transketolase activity, such asTktA, a polypeptide having ribulose-phosphate 3-epimerase, such as Rpe, a polypeptide having ribose-5-phosphate isomerase activity, such as RpiA, a polypeptide having transaldolase activity, such as TalA, a polypeptide having NADP+-dependent glucose-6-phosphate dehydrogenase, such as Zwf, a polypeptide having 2-keto-3-deoxygluconate 6-phosphate / 2-keto-4-hydroxyglutarate aldolase activity, such as Eda, and a polypeptide having a phosphogluconate dehydratase, such as Edd.

10. The recombinant microorganism of any of claims 1 to 9, which is a recombinant non-naturally occurring methanol-dependent or fully methylotrophic bacterial organism, for example Escherichia, such as E. coli, Bacillus, such as B. subtilis, Clostridium, Enterobacter, Klebsiella, Mannheimia, Pseudomonas, such as P. putida, Acinetabacter, Shewanella, Paracoccus, Ralstonia, such as / ?. eutropha, Geobacter, Zymomonas, Acetobacter, Geobacillus, Lactococcus, Streptococcus, Lactobacillus,ETHZ-37-PCTCorynebacterium, such as C glutamicum, Streptomyces, Proprionibacterium, Synechocystis, Synechococcus, Cyanobacteria, Chlorobi, and Deinococcus.

11. The recombinant microorganism of any of claims 1 to 10, which isthe designated Escherichia coli MDep_Ecoli having CCOS accession number CCOS 2133,or which is the designated Escherichia coli M Ful l_Ecoli having CCOS accession number CCOS 2146,the designated Escherichia coli MEcoli_ref_l having CCOS accession number CCOS 2032,the designated Escherichia coli MEcoli_ref_2 having CCOS accession number CCOS 2080,the designated Escherichia coli SMI having ATCC accession number PTA- 126783,or an Escherichia coli strain having a doubling time and product profile of any one of CCOS deposit accession number CCOS2133, CCOS 2146, CCOS 2032, of CCOS deposit accession number CCOS 2080, or of ATCC accession number PTA-126783.

12. A variant of a polypeptide having Mdh activity containing at least one or more amino acid substitutions, deletions and / or insertions, said variant polypeptide comprising the following amino acid residues:- an aspartic acid (D) residue corresponding to the D70 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an alanine (A) residue corresponding to the A72 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),ETHZ-37-PCT- a glutamine (Q) residue corresponding to the Q75 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a isoleucine (I) residue corresponding to the 194 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glutamine (Q) residue corresponding to the Q120 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a threonine (T) residue corresponding to the T136 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a leucine (L) residue corresponding to the L148 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a valine (V) residue corresponding to the V150 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a proline (P) residue corresponding to the P161 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an isoleucine (I) residue corresponding to the 1163 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an isoleucine (I) residue corresponding to the 1188 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S196 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- an alanine (A) residue corresponding to the A204 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a lysine (K) residue corresponding to the K205 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),ETHZ-37-PCT- a valine (V) residue corresponding to the V251 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glycine (G) residue corresponding to the G256 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S263 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S265 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a glutamine (Q) residue corresponding to the Q275 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a isoleucine (I) residue corresponding to the 1278 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a serine (S) residue corresponding to the S281 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a methionine (M) residue corresponding to the M284 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),- a leucine (L) residue corresponding to the L326 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1), and- a methionine (M) residue corresponding to the M342 residue in the homologous Bacillus methanolicus Mdh Bm MGA3 polypeptide (SEQ ID NO 1),or comprisinga sequence having at least 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 13 and / or comprising a sequence having at least 70%, 80%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 14, whereinETHZ-37-PCTsaid sequences, if both present in the polypeptide are spaced at least 40 residues apart, for example 40 to 50 or 40 to 45 residues apart.

13. The variant polypeptide of claim 12, which is a variant of a polypeptide having at least 70%, 75%, 80%, 85%, 90%, 95%, 98% or 99% sequence identity to SEQ ID NO 7.

14. An expression vector or a cell comprising a nucleic acid sequence encoding the variant polypeptide of claim 12 or 13.

15. A method for producing or for increasing production of a microbial metabolite or product, comprising the steps of growing the recombinant microorganism of any of claims 1 to 11 on a Cl compound, for example methanol, and obtaining the metabolite or product.ETHZ-37-PCT